Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	GPHN TRIM2 ANK2 ANK3 MAP2 CENPF OBSCN RABGAP1 MEFV CLIP3 LRPPRC DST ALMS1 BRCA1 MAST1 MICAL3 MYO15A KIF13A NEXN VCL HTT KIF25	1.61e-05	1099	146	22	GO:0008092
GeneOntologyMolecularFunction	tubulin binding	MAP2 CENPF RABGAP1 CLIP3 LRPPRC DST ALMS1 BRCA1 MAST1 KIF13A HTT KIF25	7.47e-05	428	146	12	GO:0015631
GeneOntologyMolecularFunction	small GTPase binding	MYCBP2 SRGAP2 RABGAP1 STRIP1 RANBP17 XPO5 AKAP13 RIMS2 GOLGA4 VCL	1.29e-04	321	146	10	GO:0031267
GeneOntologyMolecularFunction	diazepam binding	HTT GABRA6	1.59e-04	3	146	2	GO:0050809
GeneOntologyMolecularFunction	GTPase binding	MYCBP2 SRGAP2 RABGAP1 STRIP1 RANBP17 XPO5 AKAP13 RIMS2 GOLGA4 VCL	3.24e-04	360	146	10	GO:0051020
GeneOntologyMolecularFunction	microtubule binding	MAP2 CENPF CLIP3 LRPPRC DST ALMS1 MAST1 KIF13A KIF25	4.49e-04	308	146	9	GO:0008017
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	DRC7 ANK3 MAP2 SRGAP2 DDB1 CCNF FSIP2 CLIP3 DST RNF4 ALMS1 NSFL1C BRCA1 ZPR1 TPX2 CFAP206 TACC1 DNAH5 PCM1 HTT KIF25 SON WDR72	2.14e-09	720	149	23	GO:0000226
GeneOntologyBiologicalProcess	microtubule-based process	DRC7 ANK3 MAP2 WT1 COPG2 SRGAP2 DDB1 CCNF FSIP2 CLIP3 LRPPRC DST RNF4 ALMS1 NSFL1C BRCA1 ZPR1 TPX2 CFAP206 TACC1 KIF13A DNAH5 PCM1 HTT KIF25 SON WDR72	9.27e-09	1058	149	27	GO:0007017
GeneOntologyBiologicalProcess	microtubule-based movement	DRC7 ANK3 MAP2 WT1 COPG2 FSIP2 CLIP3 LRPPRC DST CFAP206 KIF13A DNAH5 PCM1 HTT KIF25	2.99e-06	493	149	15	GO:0007018
GeneOntologyBiologicalProcess	transport along microtubule	ANK3 MAP2 COPG2 CLIP3 LRPPRC DST KIF13A PCM1 HTT	1.36e-05	197	149	9	GO:0010970
GeneOntologyBiologicalProcess	microtubule-based transport	ANK3 MAP2 COPG2 CLIP3 LRPPRC DST KIF13A DNAH5 PCM1 HTT	1.58e-05	253	149	10	GO:0099111
GeneOntologyBiologicalProcess	cell junction organization	GPHN WHRN FILIP1 ANK2 ANK3 MYCBP2 TNC PCDHB14 PCDHB8 GRID1 SRGAP2 REST IGF1R DST ROBO1 RIMS2 LNX1 SDK1 VCL GABRA6	2.43e-05	974	149	20	GO:0034330
GeneOntologyBiologicalProcess	developmental growth	CPNE9 MAP2 MYCBP2 TNC OSTN WT1 ZNF416 ZNF568 IGSF10 KMT2D IGF1R ALMS1 ZPR1 B4GALNT2 ROBO1 AKAP13 RIMS2 GOLGA4 VCL	3.20e-05	911	149	19	GO:0048589
GeneOntologyBiologicalProcess	synapse organization	GPHN FILIP1 ANK3 MYCBP2 TNC PCDHB14 PCDHB8 GRID1 SRGAP2 REST IGF1R ROBO1 RIMS2 LNX1 SDK1 GABRA6	3.73e-05	685	149	16	GO:0050808
GeneOntologyBiologicalProcess	cytoskeleton-dependent intracellular transport	ANK3 MAP2 COPG2 CLIP3 LRPPRC DST KIF13A PCM1 HTT	3.88e-05	225	149	9	GO:0030705
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	5.18e-05	2	149	2	GO:0036309
GeneOntologyBiologicalProcess	developmental cell growth	CPNE9 MAP2 OSTN ZNF416 KMT2D ROBO1 AKAP13 RIMS2 GOLGA4 VCL	6.91e-05	301	149	10	GO:0048588
GeneOntologyBiologicalProcess	regulation of cell cycle process	NCAPD3 NUGGC CENPF BIRC6 DDB1 CCNF IGF1R RNF4 ALMS1 NSFL1C BRCA1 TELO2 TPX2 ANKRD17 KIF13A TP53BP1 KIF25	1.33e-04	845	149	17	GO:0010564
GeneOntologyBiologicalProcess	regulation of SA node cell action potential	ANK2 RYR2	1.55e-04	3	149	2	GO:0098907
GeneOntologyBiologicalProcess	cell growth	CPNE9 MAP2 TNC OSTN WT1 ZNF416 BAP1 KMT2D BRCA1 ROBO1 AKAP13 RIMS2 GOLGA4 VCL	1.80e-04	625	149	14	GO:0016049
GeneOntologyBiologicalProcess	growth	CPNE9 MAP2 MYCBP2 TNC OSTN WT1 ZNF416 ZNF568 BAP1 IGSF10 KMT2D IGF1R ALMS1 BRCA1 ZPR1 B4GALNT2 ROBO1 AKAP13 RIMS2 GOLGA4 VCL	2.21e-04	1235	149	21	GO:0040007
GeneOntologyBiologicalProcess	embryo development	WHRN WT1 REST TRIP12 BIRC6 ZNF568 RYR2 LUZP1 BAP1 KMT2D CMIP BRCA1 ZPR1 KIAA1217 UGDH NFRKB TDRD6 TBC1D23 MYO15A USPL1 EGFL8 HTT CDON	2.60e-04	1437	149	23	GO:0009790
GeneOntologyBiologicalProcess	cell cycle process	NCAPD3 NUGGC ANK3 CENPF BIRC6 DDB1 CCNF IGF1R RNF4 ALMS1 NSFL1C BRCA1 TELO2 ZPR1 TPX2 ANKRD17 TACC1 KIF13A PCM1 TP53BP1 HTT KIF25 SON	2.71e-04	1441	149	23	GO:0022402
GeneOntologyBiologicalProcess	regulation of cell cycle	NCAPD3 NUGGC CENPF BIRC6 DDB1 BAP1 CCNF IGF1R RNF4 ALMS1 NSFL1C BRCA1 TELO2 ZPR1 TPX2 NFRKB ANKRD17 KIF13A TP53BP1 KIF25 SON	2.77e-04	1256	149	21	GO:0051726
GeneOntologyBiologicalProcess	regulation of microtubule-based process	MAP2 CCNF CLIP3 RNF4 ALMS1 BRCA1 TPX2 CFAP206 TACC1	2.87e-04	293	149	9	GO:0032886
GeneOntologyBiologicalProcess	regulation of atrial cardiac muscle cell action potential	ANK2 RYR2	3.08e-04	4	149	2	GO:0098910
GeneOntologyBiologicalProcess	Cajal body organization	ZPR1 USPL1	3.08e-04	4	149	2	GO:0030576
GeneOntologyBiologicalProcess	protein-DNA complex organization	CENPF WT1 KDM3B REST TRIP12 DDB1 ZRANB3 NSD3 BAP1 EEF2KMT TAF3 KMT2D RNF4 UBN1 BRCA1 NFRKB KDM4B TP53BP1	3.24e-04	999	149	18	GO:0071824
GeneOntologyBiologicalProcess	developmental growth involved in morphogenesis	CPNE9 MAP2 TNC OSTN ZNF568 ROBO1 RIMS2 GOLGA4 VCL	3.33e-04	299	149	9	GO:0060560
GeneOntologyCellularComponent	sarcolemma	ANK2 ANK3 OBSCN NCSTN RYR2 IGF1R MLIP DST VCL	9.15e-06	190	149	9	GO:0042383
GeneOntologyCellularComponent	costamere	ANK2 ANK3 CMYA5 VCL	1.64e-05	22	149	4	GO:0043034
GeneOntologyCellularComponent	microtubule organizing center	WHRN CENPF RABGAP1 BIRC6 LUZP1 CCNF UBN1 ALMS1 NSFL1C BRCA1 KIAA1217 CFAP206 TACC1 RP2 NUP93 KIF13A PCM1 HTT KIF25	3.01e-05	919	149	19	GO:0005815
GeneOntologyCellularComponent	A band	ANK2 OBSCN CMYA5 RYR2 DST	3.41e-05	52	149	5	GO:0031672
GeneOntologyCellularComponent	Z disc	ANK2 ANK3 OBSCN RYR2 DST NEXN VCL	1.06e-04	151	149	7	GO:0030018
GeneOntologyCellularComponent	intercalated disc	ANK2 ANK3 OBSCN DST VCL	1.25e-04	68	149	5	GO:0014704
GeneOntologyCellularComponent	I band	ANK2 ANK3 OBSCN RYR2 DST NEXN VCL	1.91e-04	166	149	7	GO:0031674
GeneOntologyCellularComponent	nuclear envelope	UACA CENPF RYR2 RANBP17 LRPPRC TAF3 MLIP DST KCNH1 PLA2G4A ANKRD17 NUP93 PCM1	1.92e-04	560	149	13	GO:0005635
GeneOntologyCellularComponent	nuclear body	NUGGC OBSCN WT1 DGKQ CMYA5 TRIP12 MLIP RNF4 UBN1 BRCA1 TELO2 ZPR1 ACIN1 RP2 USPL1 TP53BP1 SON	2.48e-04	903	149	17	GO:0016604
GeneOntologyCellularComponent	supramolecular fiber	WHRN ANK2 ANK3 MAP2 OBSCN CMYA5 MEFV RYR2 CLIP3 LRPPRC DST RNF4 TPX2 CFAP206 AKAP13 KIF13A DNAH5 NEXN VCL KIF25	2.74e-04	1179	149	20	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	WHRN ANK2 ANK3 MAP2 OBSCN CMYA5 MEFV RYR2 CLIP3 LRPPRC DST RNF4 TPX2 CFAP206 AKAP13 KIF13A DNAH5 NEXN VCL KIF25	2.99e-04	1187	149	20	GO:0099081
GeneOntologyCellularComponent	postsynapse	GPHN WHRN FILIP1 ANK2 ANK3 MAP2 PCDHB8 RTN3 DGKQ GRID1 SRGAP2 IGF1R DST KCNH1 RNF10 LNX1 HTT GABRA6	3.46e-04	1018	149	18	GO:0098794
GeneOntologyCellularComponent	neuron to neuron synapse	GPHN ANK2 ANK3 MAP2 RTN3 GRID1 SRGAP2 DST KCNH1 RNF10 LNX1 GABRA6	3.78e-04	523	149	12	GO:0098984
GeneOntologyCellularComponent	centrosome	CENPF RABGAP1 BIRC6 LUZP1 CCNF UBN1 ALMS1 NSFL1C BRCA1 KIAA1217 TACC1 NUP93 KIF13A PCM1 KIF25	4.09e-04	770	149	15	GO:0005813
GeneOntologyCellularComponent	sarcomere	ANK2 ANK3 OBSCN CMYA5 RYR2 DST NEXN VCL	4.26e-04	249	149	8	GO:0030017
GeneOntologyCellularComponent	cell-cell contact zone	ANK2 ANK3 OBSCN DST VCL	5.67e-04	94	149	5	GO:0044291
GeneOntologyCellularComponent	periciliary membrane compartment	WHRN RP2	7.43e-04	6	149	2	GO:1990075
GeneOntologyCellularComponent	myofibril	ANK2 ANK3 OBSCN CMYA5 RYR2 DST NEXN VCL	7.79e-04	273	149	8	GO:0030016
GeneOntologyCellularComponent	synaptic membrane	GPHN ANK2 ANK3 PCDHB8 GRID1 SRGAP2 NCSTN KCNH1 RNF10 RIMS2 HTT GABRA6	9.81e-04	583	149	12	GO:0097060
GeneOntologyCellularComponent	postsynaptic specialization	GPHN ANK2 ANK3 MAP2 RTN3 GRID1 SRGAP2 DST KCNH1 RNF10 GABRA6	9.82e-04	503	149	11	GO:0099572
GeneOntologyCellularComponent	microtubule associated complex	MAP2 RABGAP1 MEFV KIF13A DNAH5 KIF25	1.05e-03	161	149	6	GO:0005875
GeneOntologyCellularComponent	contractile muscle fiber	ANK2 ANK3 OBSCN CMYA5 RYR2 DST NEXN VCL	1.15e-03	290	149	8	GO:0043292
GeneOntologyCellularComponent	M band	ANK2 OBSCN CMYA5	1.38e-03	31	149	3	GO:0031430
GeneOntologyCellularComponent	postsynaptic density	GPHN ANK2 ANK3 MAP2 RTN3 GRID1 SRGAP2 DST KCNH1 RNF10	1.50e-03	451	149	10	GO:0014069
GeneOntologyCellularComponent	microtubule	MAP2 MEFV CLIP3 LRPPRC DST RNF4 TPX2 CFAP206 KIF13A DNAH5 KIF25	1.56e-03	533	149	11	GO:0005874
GeneOntologyCellularComponent	axon hillock	MAP2 TPX2	1.76e-03	9	149	2	GO:0043203
GeneOntologyCellularComponent	axon	WHRN ANK3 MAP2 MYCBP2 COPG2 TXNRD2 IGF1R DST KCNH1 ZPR1 TPX2 MAST1 ROBO1 NEXN HTT	1.78e-03	891	149	15	GO:0030424
GeneOntologyCellularComponent	asymmetric synapse	GPHN ANK2 ANK3 MAP2 RTN3 GRID1 SRGAP2 DST KCNH1 RNF10	2.26e-03	477	149	10	GO:0032279
GeneOntologyCellularComponent	microtubule end	CLIP3 DST RNF4	2.49e-03	38	149	3	GO:1990752
GeneOntologyCellularComponent	postsynaptic membrane	GPHN ANK2 ANK3 PCDHB8 GRID1 SRGAP2 KCNH1 RNF10 GABRA6	2.54e-03	405	149	9	GO:0045211
GeneOntologyCellularComponent	ciliary basal body	WHRN CENPF ALMS1 CFAP206 RP2 PCM1	2.78e-03	195	149	6	GO:0036064
Domain	FN3	TNC OBSCN CMYA5 IGF1R ROBO1 ASTN2 SDK1 IL23R CDON	1.44e-05	185	145	9	SM00060
Domain	FN3	TNC OBSCN CMYA5 IGF1R ROBO1 ASTN2 SDK1 IL23R CDON	2.57e-05	199	145	9	PS50853
Domain	FN3_dom	TNC OBSCN CMYA5 IGF1R ROBO1 ASTN2 SDK1 IL23R CDON	3.78e-05	209	145	9	IPR003961
Domain	fn3	TNC OBSCN CMYA5 IGF1R ROBO1 SDK1 IL23R CDON	3.92e-05	162	145	8	PF00041
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FILIP1 NCAPD3 UACA MYCBP2 POLR2A KDM3B REST TRIP12 URGCP STRIP1 BAP1 TAF3 KMT2D UBN1 NSFL1C TPX2 NFRKB PLA2G4A ACIN1 ANKRD17 MICAL3 GOLGA4 PCM1 KDM4B TP53BP1 SON	4.22e-16	774	149	26	15302935
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	GPHN ANK3 MYCBP2 POLR2A KDM3B LUZP1 NSD3 GTF2E2 TAF3 KMT2D ALMS1 TPX2 NFRKB ACIN1 PCCA PCM1 VCL TP53BP1 HTT	3.12e-12	549	149	19	38280479
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	GPHN MAP2 MYCBP2 KDM3B SRGAP2 TRIP12 LUZP1 NSD3 FSIP2 LRPPRC IGF1R DST ALMS1 KIAA1217 RNF10 ANKRD17 AKAP13 NUP93 PPIP5K2 KIF13A GOLGA4 PCM1	2.05e-11	861	149	22	36931259
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MYCBP2 POLR2A MCC KDM3B SRGAP2 BIRC6 DDB1 STRIP1 NBAS ALMS1 NSFL1C TPX2 NFRKB ROBO1 AKAP13 TACC1 PPIP5K2 GOLGA4 PCM1 VCL	5.74e-11	733	149	20	34672954
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYCBP2 CENPF POLR2A COPG2 TRIP12 BIRC6 DDB1 LRPPRC DST XPO5 ACIN1 ANKRD17 HADHA NUP93 PCM1 VCL TP53BP1 SON	4.77e-10	653	149	18	22586326
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ANK3 UACA MAP2 MYCBP2 OBSCN RTN3 SRGAP2 RABGAP1 HIVEP3 RANBP17 LRPPRC CMIP IGF1R RNF4 KIAA1217 MAST1 ANKRD17 ASTN2 AKAP13 TNFRSF19 MICAL3 PCCA GOLGA4 PCM1 KDM4B HTT	1.04e-09	1489	149	26	28611215
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ANK3 KDM3B COPG2 TRIP12 BIRC6 RYR2 STRIP1 GTF2E2 DST BRCA1 PPP1R15B UGDH ROBO1 TACC1 PCCA SDK1 GOLGA4 PCM1 CDON	1.11e-09	777	149	19	35844135
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCAPD3 SANBR KDM3B NCSTN URGCP BAP1 DST USP38 TELO2 RNF10 ZBTB5 ANKRD17 NUP93 PPIP5K2 RIMS2 KDM4B	1.25e-09	529	149	16	14621295
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	ANK3 OBSCN TXNRD2 CMYA5 RYR2 FSIP2 LRPPRC DST HADHA DNAH5 PCCA VCL SON	2.18e-09	331	149	13	29199018
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYCBP2 POLR2A OBSCN KDM3B DGKQ GRID1 SRGAP2 TXNRD2 BIRC6 NSD3 BAP1 HIVEP3 KMT2D IGF1R DST UBN1 PPP1R15B C19orf44 AKAP13 MICAL3 ADAT1 HTT	2.20e-09	1105	149	22	35748872
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	GPHN ANK2 POLR2A KDM3B COPG2 SRGAP2 DDB1 GTF2E2 DST ALMS1 KIAA1217 TPX2 ACIN1 ANKRD17 TACC1 PCCA PCM1 VCL TP53BP1 SON	3.75e-09	934	149	20	33916271
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ANK2 ANK3 UACA MAP2 MYCBP2 RTN3 DDB1 SNX19 DCAF5 NBAS LRPPRC GTF2E2 NSFL1C TELO2 PPP1R15B ROBO1 AKAP13 TACC1 ALAS1 HADHA GOLGA4 PCM1 VCL TP53BP1	2.22e-08	1487	149	24	33957083
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ANK2 UACA MYCBP2 OBSCN CMYA5 BIRC6 PRKD3 LRPPRC DST ALMS1 UGDH RNF10 VCL SON	3.46e-08	497	149	14	23414517
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	MYCBP2 CENPF COPG2 RABGAP1 BIRC6 LUZP1 BAP1 KMT2D DST ALMS1 ANKRD17 PCCA PCM1	3.46e-08	418	149	13	34709266
Pubmed	Functional proteomics mapping of a human signaling pathway.	ANK3 MYCBP2 KDM3B TRIP12 DDB1 RYR2 KMT2D DST RNF4 XPO5 PPP1R15B KIF13A SDK1 VCL SON	4.30e-08	591	149	15	15231748
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	GPHN MYCBP2 RBM45 KDM3B TRIP12 STRIP1 BAP1 PRKD3 LRPPRC NSFL1C BRCA1 USP38 NFRKB ANKRD17 HADHA NUP93 USPL1 ZMYM6 TP53BP1	6.79e-08	1005	149	19	19615732
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	MYCBP2 POLR2A TRIP12 BIRC6 DDB1 LUZP1 LRPPRC DST UBN1 NSFL1C UGDH ACIN1 ANKRD17 AKAP13 HADHA NUP93 NEXN PCK2 GOLGA4 VCL TP53BP1 SON	8.09e-08	1353	149	22	29467282
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	GPHN ANK2 ANK3 MAP2 MYCBP2 SANBR RTN3 RABGAP1 BIRC6 RYR2 LRPPRC NSFL1C KIAA1217 RNF10 TACC1 HADHA PCCA PCK2 PCM1 TP53BP1	9.84e-08	1139	149	20	36417873
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	PLCD4 REST TRIP12 BIRC6 DDB1 LUZP1 TAF3 KMT2D ALMS1 TPX2 ACIN1 NUP93 TP53BP1	1.31e-07	469	149	13	27634302
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	MYCBP2 POLR2A TRIP12 LUZP1 NSD3 DST UBN1 ALMS1 NSFL1C BRCA1 TPX2 MICAL3 HADHA PCM1 KDM4B	1.33e-07	645	149	15	25281560
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	FILIP1 CENPF TRIP12 DDB1 BRCA1 XPO5 NUP93 VCL TP53BP1 SON	1.40e-07	250	149	10	33536335
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NCAPD3 CENPF POLR2A REST TRIP12 DDB1 NSD3 BAP1 KMT2D DST UBN1 BRCA1 TPX2 NFRKB ACIN1 ATF3 HADHA NUP93 PCCA ILVBL SON	1.70e-07	1294	149	21	30804502
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPHN ANK2 ANK3 UACA MYCBP2 CENPF MCC SRGAP2 DDB1 LUZP1 STRIP1 LRPPRC DST KIAA1217 ANKRD17 GOLGA4 PCM1 TP53BP1	1.83e-07	963	149	18	28671696
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	GPHN CENPF TRIP12 STRIP1 PRKD3 TPX2 PLA2G4A ACIN1 AKAP13 KIF13A PCM1 TP53BP1 SON	2.91e-07	503	149	13	16964243
Pubmed	RNF4 regulates DNA double-strand break repair in a cell cycle-dependent manner.	RNF4 BRCA1 TP53BP1	3.07e-07	4	149	3	26766492
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ANK2 MAP2 MYCBP2 TNC RTN3 STRIP1 DST MICAL3 RIMS2 PCM1 HTT	3.37e-07	347	149	11	17114649
Pubmed	SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.	GPHN COPG2 RNF4 TELO2 ACIN1 NUP93	3.41e-07	64	149	6	26511642
Pubmed	CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI.	NCAPD3 UACA COPG2 TELO2 AKAP13 MICAL3 HTT	3.45e-07	104	149	7	31240132
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	MYCBP2 CENPF RTN3 RABGAP1 BIRC6 DDB1 SNX19 LUZP1 STRIP1 NBAS LRPPRC DST ALMS1 NSFL1C TELO2 KIAA1217 PPP1R15B TACC1 ALAS1 HADHA PCK2 SON	4.48e-07	1496	149	22	32877691
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	UACA MYCBP2 POLR2A NSFL1C BRCA1 KIAA1217 PPP1R15B TPX2 ACIN1 AKAP13 SON	4.98e-07	361	149	11	30344098
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 KDM3B BIRC6 BAP1 DST ALMS1 XPO5 RNF10 KDM4B	6.02e-07	225	149	9	12168954
Pubmed	TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes.	TRIP12 BRCA1 TP53BP1	7.66e-07	5	149	3	22884692
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	UACA POLR2A MCC DDB1 DCAF5 LUZP1 NSD3 TAF3 ALMS1 BRCA1 TELO2 NFRKB ANKRD17 PCCA ILVBL PCM1 SON WDR72	1.52e-06	1116	149	18	31753913
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	CENPF POLR2A COPG2 LUZP1 TPX2 PLA2G4A ANKRD17 ROBO1 PCM1	1.75e-06	256	149	9	33397691
Pubmed	A comprehensive resource of interacting protein regions for refining human transcription factor networks.	ANK2 ANK3 MAP2 COPG2 RYR2 IGF1R ACIN1 TP53BP1	1.84e-06	191	149	8	20195357
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	GPHN CENPF KDM3B LUZP1 GTF2E2 DST TPX2 ACIN1 HADHA VCL TP53BP1 SON	2.07e-06	506	149	12	30890647
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ANK3 MYCBP2 POLR2A RTN3 COPG2 DDB1 HIVEP3 NBAS LRPPRC DST AKAP13 HADHA MYO15A PCCA VCL	2.20e-06	807	149	15	30575818
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	NCAPD3 CENPF POLR2A COPG2 TRIP12 BIRC6 NBAS ANKRD17 HADHA TBC1D23 DNAH5 PCK2 TP53BP1 SON	2.25e-06	704	149	14	29955894
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NCAPD3 POLR2A KDM3B DDB1 KMT2D NSFL1C TPX2 UGDH ACIN1 TP53BP1	2.36e-06	341	149	10	32971831
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ANK2 ANK3 COPG2 DDB1 LRPPRC DST NSFL1C XPO5 ANKRD17 ROBO1 MICAL3 HADHA GOLGA4 VCL	2.40e-06	708	149	14	39231216
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MYCBP2 CD109 KDM3B RTN3 NCSTN TRIP12 BIRC6 LUZP1 NSD3 LRPPRC DST XPO5 TPX2 ROBO1 AKAP13 HADHA ILVBL PCM1 TP53BP1	3.12e-06	1297	149	19	33545068
Pubmed	Mapping brain gene coexpression in daytime transcriptomes unveils diurnal molecular networks and deciphers perturbation gene signatures.	WT1 KDM3B REST KDM4B HTT	3.28e-06	53	149	5	36265442
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPHN ANK2 ANK3 MAP2 TNC RTN3 SRGAP2 DDB1 LUZP1 STRIP1 LRPPRC GTF2E2 MLIP DST KIAA1217 MAST1 MICAL3 HADHA PCM1 VCL	3.40e-06	1431	149	20	37142655
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	POLR2A COPG2 TRIP12 LUZP1 NSD3 GTF2E2 TAF3 UBN1 BRCA1 TPX2 NFRKB ACIN1 PCCA PCM1 TP53BP1 SON	3.70e-06	954	149	16	36373674
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	NCAPD3 UACA CD109 COPG2 DDB1 SNX19 NBAS LRPPRC DST UBN1 XPO5 TELO2 MICAL3 ATF3 HADHA NUP93 NEXN ILVBL PCK2 PCM1	3.73e-06	1440	149	20	30833792
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	SRGAP2 LUZP1 DST KIAA1217 ACIN1 MICAL3 NUP93 PPIP5K2 GOLGA4 TP53BP1	3.81e-06	360	149	10	33111431
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	WT1 KDM3B COPG2 TRIP12 BAP1 LRPPRC TAF3 NSFL1C XPO5 NFRKB ACIN1 HADHA NUP93 PPIP5K2 PCCA SREK1IP1 ILVBL PCK2 SON	3.92e-06	1318	149	19	30463901
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	NCAPD3 MYCBP2 TRIP12 URGCP STRIP1 LRPPRC DST ANKRD17	3.98e-06	212	149	8	33853758
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	TRIM2 ANK2 CENPF SRGAP2 RABGAP1 DST GOLGA4	4.24e-06	151	149	7	17043677
Pubmed	Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.	ANK3 OBSCN VCL	4.25e-06	8	149	3	28826662
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ANK3 OBSCN COPG2 SRGAP2 NCSTN TRIP12 DCAF5 ZNF568 ZRANB3 KCNH1 NFRKB ACIN1 ANKRD17 RP2 KIF13A NEXN TP53BP1	4.40e-06	1084	149	17	11544199
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	LUZP1 LRPPRC DST ACIN1 HADHA NUP93 NEXN PCK2 PCM1 VCL SON	7.27e-06	477	149	11	31300519
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	PKD1L2 BIRC6 RYR2 LUZP1 IGSF10 FSIP2 AKAP13	8.54e-06	168	149	7	30631154
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	GPHN UACA CENPF POLR2A MCC DDB1 STRIP1 BAP1 NBAS TPX2 MICAL3 HADHA NUP93 NEXN PCM1 VCL TP53BP1	1.01e-05	1155	149	17	20360068
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NUGGC ANK3 MAP2 CENPF POLR2A OBSCN TRIP12 DDB1 IGF1R MICAL3 KDM4B	1.07e-05	497	149	11	36774506
Pubmed	Human transcription factor protein interaction networks.	DDB1 DCAF5 BAP1 TAF3 KMT2D DST UBN1 ALMS1 BRCA1 TPX2 NFRKB ANKRD17 HADHA NUP93 PCCA ILVBL PCM1 VCL TP53BP1	1.23e-05	1429	149	19	35140242
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3B TRIP12 DDB1 NSD3 BAP1 FSIP2 TAF3 UBN1 BRCA1 TPX2 NFRKB KDM4B	1.32e-05	608	149	12	36089195
Pubmed	Hypertrophic Cardiomyopathy Overview	OBSCN RYR2 NEXN VCL	1.36e-05	34	149	4	20301725
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ANK3 UACA SRGAP2 LRPPRC IGF1R DST KIAA1217 ROBO1 MICAL3 PCK2	1.49e-05	421	149	10	36976175
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	UACA MYCBP2 SRGAP2 TRIP12 LUZP1 NSFL1C BRCA1 UGDH ANKRD17 AKAP13 HADHA VCL SON	1.55e-05	724	149	13	36232890
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	GPHN MAP2 POLR2A KDM3B RABGAP1 CMYA5 BIRC6 DDB1 GTF2E2 NSFL1C XPO5 TELO2 ZPR1 UGDH NFRKB PLA2G4A KIF13A VCL HTT	1.58e-05	1455	149	19	22863883
Pubmed	Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.	POLR2A BRCA1 TP53BP1	1.65e-05	12	149	3	28700933
Pubmed	A shared vesicular carrier allows synaptic corelease of GABA and glycine.	GPHN MAP2 RIMS2	1.65e-05	12	149	3	16701208
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	ANK3 WT1 MCC TRIP12 ZRANB3 RNF4 UBN1 TPX2 AKAP13 SON	1.78e-05	430	149	10	35044719
Pubmed	53BP1, a mediator of the DNA damage checkpoint.	BRCA1 TP53BP1	1.82e-05	2	149	2	12364621
Pubmed	Mutant analysis reveals whirlin as a dynamic organizer in the growing hair cell stereocilium.	WHRN MYO15A	1.82e-05	2	149	2	15590699
Pubmed	Replicated chromatin curtails 53BP1 recruitment in BRCA1-proficient and BRCA1-deficient cells.	BRCA1 TP53BP1	1.82e-05	2	149	2	33811064
Pubmed	Whirler mutant hair cells have less severe pathology than shaker 2 or double mutants.	WHRN MYO15A	1.82e-05	2	149	2	17619105
Pubmed	The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia.	BAP1 BRCA1	1.82e-05	2	149	2	26118501
Pubmed	Functional crosstalk between DNA damage response proteins 53BP1 and BRCA1 regulates double strand break repair choice.	BRCA1 TP53BP1	1.82e-05	2	149	2	26615718
Pubmed	BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance.	BRCA1 TP53BP1	1.82e-05	2	149	2	30257212
Pubmed	Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity.	POLR2A BRCA1	1.82e-05	2	149	2	12955082
Pubmed	BAP1 loss induces mitotic defects in mesothelioma cells through BRCA1-dependent and independent mechanisms.	BAP1 BRCA1	1.82e-05	2	149	2	36550359
Pubmed	[Myoglobinuria caused by McArdle's disease complicated by anuric acute renal insufficiency].	POLR2A BRCA1	1.82e-05	2	149	2	4506230
Pubmed	BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair.	BRCA1 TP53BP1	1.82e-05	2	149	2	22553214
Pubmed	Differences in 53BP1 and BRCA1 regulation between cycling and non-cycling cells.	BRCA1 TP53BP1	1.82e-05	2	149	2	24091731
Pubmed	ATF3 promotes migration and M1/M2 polarization of macrophages by activating tenascin‑C via Wnt/β‑catenin pathway.	TNC ATF3	1.82e-05	2	149	2	28714032
Pubmed	Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.	RYR2 HTT	1.82e-05	2	149	2	32897880
Pubmed	Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.	REST HTT	1.82e-05	2	149	2	23145961
Pubmed	53BP1 ablation rescues genomic instability in mice expressing 'RING-less' BRCA1.	BRCA1 TP53BP1	1.82e-05	2	149	2	27670884
Pubmed	Deubiquitinase BAP1 regulates stability of BRCA1 protein and inactivates the NF-κB signaling to protect mice from sepsis-induced acute kidney injury.	BAP1 BRCA1	1.82e-05	2	149	2	37414201
Pubmed	BRCA1 Directs the Repair Pathway to Homologous Recombination by Promoting 53BP1 Dephosphorylation.	BRCA1 TP53BP1	1.82e-05	2	149	2	28076794
Pubmed	A microchip platform for structural oncology applications.	POLR2A BRCA1	1.82e-05	2	149	2	27583302
Pubmed	53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.	BRCA1 TP53BP1	1.82e-05	2	149	2	20362325
Pubmed	53BP1 is a positive regulator of the BRCA1 promoter.	BRCA1 TP53BP1	1.82e-05	2	149	2	15970701
Pubmed	The interplay between BRCA1 and 53BP1 influences death, aging, senescence and cancer.	BRCA1 TP53BP1	1.82e-05	2	149	2	20724228
Pubmed	Mechanisms of synthetic lethality between BRCA1/2 and 53BP1 deficiencies and DNA polymerase theta targeting.	BRCA1 TP53BP1	1.82e-05	2	149	2	38030626
Pubmed	BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.	BAP1 BRCA1	1.82e-05	2	149	2	9528852
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	1.82e-05	2	149	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	1.82e-05	2	149	2	25383926
Pubmed	Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.	BAP1 BRCA1	1.82e-05	2	149	2	35051358
Pubmed	53BP1 and BRCA1 control pathway choice for stalled replication restart.	BRCA1 TP53BP1	1.82e-05	2	149	2	29106372
Pubmed	BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1.	BRCA1 TP53BP1	1.82e-05	2	149	2	35017534
Pubmed	DNA repair pathways to regulate response to chemoradiotherapy in patients with locally advanced head and neck cancer.	BRCA1 TP53BP1	1.82e-05	2	149	2	27465548
Pubmed	53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.	BRCA1 TP53BP1	1.82e-05	2	149	2	20453858
Pubmed	Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.	REST HTT	1.82e-05	2	149	2	12881722
Pubmed	SUMO-Targeted Ubiquitin Ligases (STUbLs) Reduce the Toxicity and Abnormal Transcriptional Activity Associated With a Mutant, Aggregation-Prone Fragment of Huntingtin.	RNF4 HTT	1.82e-05	2	149	2	30279700
Pubmed	BRCA1 associates with processive RNA polymerase II.	POLR2A BRCA1	1.82e-05	2	149	2	14506230
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	UACA DDB1 LUZP1 LRPPRC IGF1R DST HADHA	1.96e-05	191	149	7	33762435
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	GPHN NCAPD3 CD109 MCC NCSTN DDB1 LUZP1 LRPPRC XPO5 TELO2 UGDH ANKRD17 NUP93 PCM1 VCL	2.05e-05	974	149	15	28675297
Interaction	PFN1 interactions	GPHN ANK2 RTN3 SRGAP2 RABGAP1 BIRC6 BAP1 CCNF NBAS ALMS1 BRCA1 KIAA1217 AKAP13 MICAL3 KIF13A GOLGA4 VCL TP53BP1 HTT	5.87e-09	509	147	19	int:PFN1
Interaction	KDM1A interactions	MYCBP2 CENPF POLR2A COPG2 RABGAP1 BIRC6 DDB1 LUZP1 BAP1 KMT2D DST ALMS1 NSFL1C BRCA1 USP38 XPO5 KIAA1217 RNF10 ANKRD17 TACC1 PCCA PCM1 TP53BP1 HTT	8.25e-08	941	147	24	int:KDM1A
Interaction	RCOR1 interactions	MYCBP2 CENPF COPG2 RABGAP1 REST BIRC6 LUZP1 BAP1 KMT2D DST ALMS1 ZBTB5 ANKRD17 PCCA PCM1 TP53BP1	6.81e-07	494	147	16	int:RCOR1
Interaction	TOP3B interactions	MYCBP2 CENPF POLR2A OBSCN KDM3B DGKQ GRID1 SRGAP2 TXNRD2 BIRC6 NSD3 BAP1 CCNF HIVEP3 KMT2D IGF1R DST UBN1 XPO5 PPP1R15B C19orf44 ACIN1 ANKRD17 AKAP13 MICAL3 HADHA ADAT1 TP53BP1 HTT	7.42e-07	1470	147	29	int:TOP3B
Interaction	SIRT7 interactions	MYCBP2 CENPF POLR2A COPG2 TRIP12 BIRC6 DDB1 DCAF5 LRPPRC DST XPO5 ACIN1 ANKRD17 HADHA NUP93 PCM1 VCL TP53BP1 SON	2.08e-06	744	147	19	int:SIRT7
Interaction	NDC80 interactions	UACA BIRC6 LUZP1 CCNF RNF4 ALMS1 XPO5 KIAA1217 C19orf44 LNX1 PCM1 VCL	3.19e-06	312	147	12	int:NDC80
Interaction	YWHAG interactions	GPHN UACA MAP2 MYCBP2 MCC KDM3B RTN3 SRGAP2 TRIP12 LUZP1 BAP1 CCNF IGF1R DST ALMS1 ACIN1 ANKRD17 AKAP13 PPIP5K2 KIF13A LNX1 PCM1 VCL HTT SON	3.75e-06	1248	147	25	int:YWHAG
Interaction	YWHAH interactions	UACA MAP2 MYCBP2 KDM3B SRGAP2 TRIP12 LUZP1 NSD3 BAP1 CCNF DST ALMS1 KIAA1217 RNF10 MAST1 ANKRD17 AKAP13 PPIP5K2 RIMS2 GOLGA4 PCM1 VCL HTT	4.95e-06	1102	147	23	int:YWHAH
Interaction	TERF2 interactions	CENPF REST DDB1 RYR2 DST RNF4 BRCA1 UGDH NFRKB TDRD6 PCM1 TP53BP1	7.66e-06	340	147	12	int:TERF2
Interaction	PHF21A interactions	MYCBP2 CENPF RABGAP1 BIRC6 DDB1 LUZP1 BAP1 KMT2D DST ALMS1 PCCA PCM1	8.37e-06	343	147	12	int:PHF21A
Interaction	PRMT5 interactions	POLR2A KDM3B DDB1 BAP1 CCNF LRPPRC DST RNF4 NSFL1C BRCA1 MAST1 LNX1 GOLGA4 HTT	9.38e-06	471	147	14	int:PRMT5
Interaction	MAP1LC3A interactions	ANK2 ANK3 RTN3 RABGAP1 BIRC6 MEFV AKAP13 HADHA TP53BP1 HTT	1.13e-05	241	147	10	int:MAP1LC3A
Interaction	SNAP91 interactions	DCAF5 BRCA1 ACIN1 PCM1 VCL HTT	1.21e-05	70	147	6	int:SNAP91
Interaction	ACTB interactions	MAP2 RBM45 POLR2A SRGAP2 DDB1 LUZP1 BAP1 CCNF FSIP2 DST RNF4 ALMS1 NFRKB ATF3 HADHA DNAH5 NEXN IL23R PCM1 ZMYM6 VCL HTT	1.24e-05	1083	147	22	int:ACTB
Interaction	PSMC5 interactions	MAP2 BIRC6 DDB1 STRIP1 BAP1 CCNF LRPPRC IGF1R RNF4 BRCA1 CFAP206 GOLGA4 TP53BP1 HTT	1.27e-05	484	147	14	int:PSMC5
Interaction	ACTC1 interactions	GPHN RBM45 CENPF KDM3B LUZP1 BAP1 GTF2E2 DST RNF4 TPX2 ACIN1 HADHA NEXN IL23R VCL TP53BP1 SON	1.28e-05	694	147	17	int:ACTC1
Interaction	HOXC4 interactions	RABGAP1 NSD3 MAST1 ANKRD17 HTT	1.32e-05	42	147	5	int:HOXC4
Interaction	USP9X interactions	GPHN ANK3 RBM45 PLCD4 BAP1 CCNF IGF1R BRCA1 MAST1 HADHA LNX1 PCM1 HTT	1.36e-05	422	147	13	int:USP9X
Interaction	CTNNB1 interactions	ANK2 ANK3 UACA POLR2A DDB1 BAP1 CCNF LRPPRC KMT2D IGF1R DST RNF4 NSFL1C BRCA1 KIAA1217 MAST1 NUP93 LNX1 VCL HTT CDON	1.40e-05	1009	147	21	int:CTNNB1
Interaction	GTF2H4 interactions	POLR2A MCC DDB1 RNF4 BRCA1 SREK1IP1 TP53BP1	1.44e-05	108	147	7	int:GTF2H4
Interaction	YWHAB interactions	NCAPD3 UACA MAP2 MYCBP2 MCC RTN3 SRGAP2 TRIP12 LUZP1 BAP1 CCNF IGF1R DST MAST1 ANKRD17 AKAP13 PPIP5K2 LNX1 PCM1 HTT SON	1.50e-05	1014	147	21	int:YWHAB
Interaction	PLEC interactions	GPHN NCAPD3 ANK3 MAP2 URGCP LUZP1 BAP1 DST RNF4 BRCA1 PPIP5K2 DNAH5 HTT	1.66e-05	430	147	13	int:PLEC
Interaction	HDAC1 interactions	MYCBP2 CENPF COPG2 RABGAP1 REST BIRC6 DDB1 LUZP1 BAP1 CCNF LRPPRC KMT2D DST ALMS1 BRCA1 USP38 ZBTB5 ANKRD17 ATF3 PCCA GOLGA4 PCM1	1.77e-05	1108	147	22	int:HDAC1
Interaction	SLFN11 interactions	FILIP1 CENPF TRIP12 DDB1 BAP1 CCNF BRCA1 XPO5 NUP93 VCL TP53BP1 SON	2.09e-05	376	147	12	int:SLFN11
Interaction	EGLN3 interactions	GPHN NCAPD3 MYCBP2 CENPF POLR2A MCC KDM3B BIRC6 DDB1 LRPPRC BRCA1 TELO2 TPX2 UGDH RNF10 ZBTB5 ANKRD17 ROBO1 AKAP13 HADHA NUP93 PPIP5K2 LNX1 PCM1	2.22e-05	1296	147	24	int:EGLN3
Interaction	EPM2AIP1 interactions	MYCBP2 CCNF RNF4 BRCA1 MICAL3 LNX1	2.27e-05	78	147	6	int:EPM2AIP1
Interaction	TNIK interactions	TRIM2 ANK2 ANK3 MYCBP2 CENPF STRIP1 DST KIAA1217 GOLGA4 PCM1 TP53BP1 HTT	2.38e-05	381	147	12	int:TNIK
Interaction	UBE2L3 interactions	MYCBP2 POLR2A TRIP12 BAP1 CCNF BRCA1 ZPR1 PCK2 TP53BP1	2.52e-05	211	147	9	int:UBE2L3
Interaction	SMARCC1 interactions	MYCBP2 POLR2A DDB1 STRIP1 NSD3 CCNF RNF4 UBN1 BRCA1 PPIP5K2 GOLGA4 TP53BP1	2.57e-05	384	147	12	int:SMARCC1
Interaction	NAA40 interactions	GPHN ANK2 POLR2A KDM3B COPG2 SRGAP2 DDB1 GTF2E2 DST ALMS1 KIAA1217 TPX2 ACIN1 ANKRD17 TACC1 PCCA PCM1 VCL TP53BP1 SON	2.93e-05	978	147	20	int:NAA40
Interaction	YWHAZ interactions	NCAPD3 UACA MAP2 MYCBP2 MCC SRGAP2 TRIP12 LUZP1 BAP1 CCNF FSIP2 LRPPRC IGF1R DST BRCA1 MAST1 ANKRD17 AKAP13 PPIP5K2 LNX1 PCM1 VCL TP53BP1 HTT	2.94e-05	1319	147	24	int:YWHAZ
Interaction	MGST3 interactions	CLCA4 BIRC6 CCNF LRPPRC RNF4 TACC1 HADHA NUP93 TP53BP1 HTT	2.99e-05	270	147	10	int:MGST3
Interaction	VPS35 interactions	MYCBP2 MCC DDB1 BAP1 CCNF RNF4 BRCA1 GOLGA4 PCM1 HTT	2.99e-05	270	147	10	int:VPS35
Interaction	PHLPP1 interactions	CENPF POLR2A COPG2 CMYA5 LUZP1 KIAA1217 TPX2 PLA2G4A ANKRD17 ROBO1 PCM1	3.41e-05	333	147	11	int:PHLPP1
Interaction	SEPTIN7 interactions	NCSTN BAP1 CCNF KMT2D MLIP BRCA1 ACIN1 HTT SON	4.62e-05	228	147	9	int:SEPTIN7
Interaction	YAP1 interactions	GPHN ANK3 UACA MAP2 POLR2A WT1 KDM3B LUZP1 NSD3 GTF2E2 TAF3 KMT2D IGF1R ZPR1 TPX2 NFRKB ACIN1 HADHA RP2 PCCA VCL	4.65e-05	1095	147	21	int:YAP1
Interaction	SFN interactions	MAP2 MYCBP2 SRGAP2 TRIP12 LUZP1 BAP1 IGF1R DST ALMS1 NSFL1C ANKRD17 AKAP13 NUP93 KIF13A VCL HTT	4.69e-05	692	147	16	int:SFN
Interaction	IPO5 interactions	DDB1 ABCC6 BAP1 CCNF LRPPRC RNF4 BRCA1 MAST1 TBC1D23 GOLGA4 PCM1 HTT	5.32e-05	414	147	12	int:IPO5
Interaction	ANKRD28 interactions	WHRN ANK2 ANK3 UACA RTN3 CCNF BRCA1 PLA2G4A PPIP5K2	5.84e-05	235	147	9	int:ANKRD28
Interaction	MAGEB18 interactions	LNX1 TP53BP1 HTT	6.01e-05	11	147	3	int:MAGEB18
Interaction	YWHAQ interactions	UACA MAP2 MYCBP2 SRGAP2 TRIP12 MEFV LUZP1 BAP1 CCNF LRPPRC IGF1R DST BRCA1 ANKRD17 AKAP13 HADHA PPIP5K2 LNX1 PCM1 VCL HTT	6.26e-05	1118	147	21	int:YWHAQ
Interaction	MYH6 interactions	POLR2A DST DNAH5 VCL HTT SON	6.53e-05	94	147	6	int:MYH6
Interaction	DYNLT1 interactions	DDB1 LUZP1 BAP1 CCNF DST NSFL1C NFRKB LNX1 PCCA	7.09e-05	241	147	9	int:DYNLT1
Interaction	STX4 interactions	ANK3 UACA CENPF RTN3 SNX19 NBAS RNF4 NSFL1C ROBO1 MICAL3 TACC1 GOLGA4	7.31e-05	428	147	12	int:STX4
Interaction	SENP3 interactions	GPHN NCAPD3 MYCBP2 COPG2 TRIP12 CCNF KMT2D TELO2 ACIN1 NUP93	7.46e-05	301	147	10	int:SENP3
Interaction	SUZ12 interactions	WT1 PLCD4 REST TRIP12 BIRC6 DDB1 CCNF TAF3 KMT2D ALMS1 BRCA1 ACIN1 NUP93 HTT SON	7.55e-05	644	147	15	int:SUZ12
Interaction	CBX3 interactions	POLR2A REST TRIP12 DDB1 ZNF568 NSD3 BAP1 CCNF GTF2E2 RNF4 BRCA1 TPX2 NFRKB NUP93 TP53BP1	7.82e-05	646	147	15	int:CBX3
Interaction	RNF168 interactions	TRIP12 RNF4 BRCA1 ALAS1 PCM1 TP53BP1	8.24e-05	98	147	6	int:RNF168
Interaction	HERC2 interactions	ANK2 MYCBP2 ARRDC5 COPG2 SRGAP2 BIRC6 CCNF KMT2D DST BRCA1 ZBTB5 PCM1 TP53BP1	8.31e-05	503	147	13	int:HERC2
Interaction	COPB2 interactions	RTN3 COPG2 BIRC6 BAP1 CCNF NBAS RNF4 BRCA1 TELO2 PPIP5K2 ILVBL	8.79e-05	370	147	11	int:COPB2
Interaction	ASF1A interactions	CENPF POLR2A NSD3 KMT2D UBN1 BRCA1 TPX2 NFRKB ZMYM6	9.09e-05	249	147	9	int:ASF1A
Interaction	SIRPA interactions	TRIM2 ANK3 IGF1R RNF4 NEXN HTT	9.23e-05	100	147	6	int:SIRPA
Interaction	GABARAP interactions	GPHN ANK2 ANK3 RTN3 BIRC6 MEFV PCM1	9.50e-05	145	147	7	int:GABARAP
Interaction	MAPRE1 interactions	MAP2 CD109 LUZP1 BAP1 CCNF IGSF10 DST ALMS1 KIAA1217 TACC1 NUP93 NEXN PCM1	1.03e-04	514	147	13	int:MAPRE1
Interaction	PSMD6 interactions	DDB1 BAP1 CCNF LRPPRC RNF4 BRCA1 TELO2 GOLGA4 TP53BP1 HTT	1.14e-04	317	147	10	int:PSMD6
Interaction	ANK3 interactions	GPHN ANK2 ANK3 BAP1 CCNF KIAA1217 MICAL3 NEXN	1.16e-04	201	147	8	int:ANK3
Interaction	UBE2D2 interactions	TRIM2 MYCBP2 TRIP12 LUZP1 RNF4 BRCA1 ZPR1 RNF10 PPIP5K2 LNX1	1.17e-04	318	147	10	int:UBE2D2
Interaction	MICAL2 interactions	DST RNF4 BRCA1 MICAL3	1.19e-04	35	147	4	int:MICAL2
Interaction	MYH9 interactions	UACA CD109 KDM3B LUZP1 BAP1 CCNF LRPPRC DST NSFL1C BRCA1 MICAL3 LNX1 DNAH5 NEXN GOLGA4 VCL	1.28e-04	754	147	16	int:MYH9
Interaction	GTF2H1 interactions	POLR2A MCC TXNRD2 GTF2E2 KIF13A TP53BP1	1.34e-04	107	147	6	int:GTF2H1
Interaction	CTDP1 interactions	NCAPD3 UACA POLR2A COPG2 TELO2 AKAP13 MICAL3 HTT	1.42e-04	207	147	8	int:CTDP1
Interaction	HNRNPF interactions	RBM45 POLR2A RABGAP1 NCSTN REST DDB1 BAP1 CCNF LRPPRC RNF4 BRCA1 ZPR1 LNX1 GOLGA4	1.47e-04	607	147	14	int:HNRNPF
Interaction	PTEN interactions	POLR2A RTN3 BIRC6 DDB1 LUZP1 BAP1 IGSF10 FSIP2 LRPPRC IGF1R NSFL1C MAST1 AKAP13 HADHA USPL1 PCCA TP53BP1 SON	1.49e-04	929	147	18	int:PTEN
Interaction	FBXO22 interactions	NUGGC ANK3 MAP2 CENPF POLR2A OBSCN TRIP12 DDB1 CCNF IGF1R MICAL3 KDM4B TP53BP1	1.68e-04	540	147	13	int:FBXO22
Interaction	PPP5C interactions	MAP2 RTN3 BIRC6 DDB1 BAP1 PLA2G4A HADHA VCL TP53BP1	1.77e-04	272	147	9	int:PPP5C
Interaction	PPP1CA interactions	GPHN MYCBP2 POLR2A RABGAP1 DDB1 RYR2 BAP1 CCNF BRCA1 PPP1R15B HADHA KIF13A LNX1 HTT SON	1.77e-04	696	147	15	int:PPP1CA
Interaction	SKA1 interactions	MYCBP2 CCNF ILVBL PCM1 VCL	1.82e-04	72	147	5	int:SKA1
Interaction	MCC interactions	WHRN UACA MCC LUZP1 STRIP1 GTF2E2 MAST1 PCCA	1.85e-04	215	147	8	int:MCC
Interaction	EPHB2 interactions	ANK2 ANK3 UACA MYCBP2 SRGAP2 RNF4 HADHA LNX1	1.91e-04	216	147	8	int:EPHB2
Interaction	NUP43 interactions	TRIP12 DDB1 RYR2 NSD3 FSIP2 TAF3 KMT2D DST RNF4 BRCA1 NFRKB ACIN1 NUP93 SON	1.98e-04	625	147	14	int:NUP43
Interaction	HSP90AB1 interactions	ANK3 MYCBP2 RBM45 CENPF MCC BAP1 CCNF LRPPRC GTF2E2 IGF1R RNF4 BRCA1 MAST1 PLA2G4A ACIN1 HADHA MYO15A HTT	2.24e-04	960	147	18	int:HSP90AB1
Interaction	UBE2D4 interactions	TRIM2 TRIP12 URGCP RNF4 RNF10 LNX1	2.40e-04	119	147	6	int:UBE2D4
Interaction	TP73 interactions	WT1 DDB1 LRPPRC BRCA1 CFAP206 ATF3 TP53BP1	2.45e-04	169	147	7	int:TP73
Interaction	USPL1 interactions	POLR2A BAP1 USPL1 TP53BP1	2.45e-04	42	147	4	int:USPL1
Interaction	KIAA1328 interactions	EEF2KMT CFAP206 LNX1 PCM1	2.45e-04	42	147	4	int:KIAA1328
Interaction	MTOR interactions	GPHN MYCBP2 DDB1 CCNF IGF1R BRCA1 TELO2 RP2 ILVBL HTT	2.49e-04	349	147	10	int:MTOR
Interaction	KPNA1 interactions	MYCBP2 RBM45 CENPF TRIP12 BAP1 CCNF TPX2 LNX1 SREK1IP1 TP53BP1	2.60e-04	351	147	10	int:KPNA1
Interaction	XPO5 interactions	RBM45 BAP1 CCNF IGF1R RNF4 XPO5 UGDH ILVBL	2.67e-04	227	147	8	int:XPO5
Interaction	CALB1 interactions	POLR2A REST HTT	2.86e-04	18	147	3	int:CALB1
Interaction	SPTAN1 interactions	GPHN NCAPD3 ANK3 MYCBP2 STRIP1 BAP1 CCNF DST NSFL1C BRCA1 VCL HTT	2.88e-04	496	147	12	int:SPTAN1
Interaction	VCP interactions	GPHN MYCBP2 POLR2A MCC KDM3B RABGAP1 NCSTN TRIP12 BAP1 CCNF LRPPRC RNF4 NSFL1C BRCA1 TELO2 PPP1R15B UGDH HADHA LNX1 VCL TP53BP1 HTT SON	2.90e-04	1435	147	23	int:VCP
Interaction	MORC3 interactions	DST RNF4 BRCA1 TP53BP1 HTT	2.99e-04	80	147	5	int:MORC3
Interaction	TOLLIP interactions	KDM3B RTN3 TRIP12 LUZP1 CCNF TPX2 ROBO1 HADHA TP53BP1 HTT	3.05e-04	358	147	10	int:TOLLIP
Interaction	HPRT1 interactions	MCC BAP1 EEF2KMT CCNF BRCA1 SREK1IP1	3.13e-04	125	147	6	int:HPRT1
Interaction	PCDHB8 interactions	PCDHB8 NSFL1C	3.14e-04	4	147	2	int:PCDHB8
Interaction	RAE1 interactions	MAP2 MYCBP2 BAP1 PRKD3 CCNF NUP93 PCM1 HTT	3.46e-04	236	147	8	int:RAE1
Interaction	CELSR3 interactions	UACA REST TRIP12 DST	3.49e-04	46	147	4	int:CELSR3
Interaction	RBBP7 interactions	MYCBP2 RBM45 REST BIRC6 DDB1 BAP1 CCNF LRPPRC RNF4 UBN1 BRCA1 GOLGA4	3.50e-04	507	147	12	int:RBBP7
Interaction	GJA1 interactions	ANK3 UACA COPG2 RABGAP1 NBAS IGF1R DST KIAA1217 ROBO1 TACC1 SDK1 GOLGA4 HTT	3.52e-04	583	147	13	int:GJA1
Interaction	DHX9 interactions	MAP2 RBM45 POLR2A REST NSD3 BAP1 CCNF LRPPRC RNF4 UBN1 BRCA1 ACIN1 HTT SON	3.55e-04	662	147	14	int:DHX9
Interaction	SLK interactions	RABGAP1 BAP1 CCNF LRPPRC GTF2E2 NSFL1C VCL	3.97e-04	183	147	7	int:SLK
Interaction	SUMO2 interactions	NCAPD3 POLR2A TRIP12 DST RNF4 BRCA1 XPO5 TPX2 ACIN1 ALAS1 USPL1 TP53BP1 HTT	4.00e-04	591	147	13	int:SUMO2
Interaction	GBF1 interactions	COPG2 BIRC6 BAP1 CCNF RNF4 BRCA1 ZPR1 PPP1R15B PLA2G4A ANKRD17 VCL	4.08e-04	442	147	11	int:GBF1
Interaction	S100A11 interactions	BAP1 CCNF PLA2G4A TACC1 HADHA	4.18e-04	86	147	5	int:S100A11
Interaction	UBE2E3 interactions	TRIM2 DDB1 RNF4 BRCA1 RNF10 HTT	4.19e-04	132	147	6	int:UBE2E3
Interaction	TNPO1 interactions	BAP1 CCNF IGF1R RNF4 BRCA1 UGDH ACIN1 HADHA RP2	4.21e-04	306	147	9	int:TNPO1
Interaction	PSMD13 interactions	MAP2 BAP1 PRKD3 CCNF LRPPRC BRCA1 GOLGA4 TP53BP1 HTT	4.21e-04	306	147	9	int:PSMD13
Interaction	TRIM28 interactions	NCAPD3 MYCBP2 RBM45 CENPF POLR2A COPG2 REST TRIP12 BIRC6 DDB1 ZNF416 BAP1 CCNF NBAS RNF4 BRCA1 ANKRD17 HADHA TBC1D23 DNAH5 PCK2 TP53BP1 SON	4.25e-04	1474	147	23	int:TRIM28
Interaction	SYNGAP1 interactions	ANK2 MAP2 MYCBP2 SRGAP2 BIRC6 RNF4 AKAP13 LNX1 TP53BP1	4.31e-04	307	147	9	int:SYNGAP1
Interaction	SEPTIN2 interactions	NCSTN BAP1 CCNF BRCA1 XPO5 ACIN1 SON	4.38e-04	186	147	7	int:SEPTIN2
GeneFamily	Fibronectin type III domain containing	TNC OBSCN CMYA5 IGF1R ROBO1 ASTN2 SDK1 CDON	2.53e-06	160	98	8	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	OBSCN IGSF10 ROBO1 NEXN SDK1 CDON	2.43e-04	161	98	6	593
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	MAP2 CMYA5 AKAP13	5.09e-04	29	98	3	396
GeneFamily	Tudor domain containing	TDRD6 KDM4B TP53BP1	1.05e-03	37	98	3	780
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TRIM2 MYCBP2 CENPF KDM3B SRGAP2 RABGAP1 TRIP12 NBAS LRPPRC GTF2E2 IGF1R DST BRCA1 ANKRD17 AKAP13 MICAL3 PPIP5K2 PCCA GOLGA4 VCL TP53BP1 SON	3.48e-09	856	149	22	M4500
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	GPHN ANK2 ANK3 IGF1R ASTN2 AKAP13 TACC1 PCCA SDK1 GOLGA4 WDR72	5.95e-08	221	149	11	M39222
Coexpression	HALLMARK_MITOTIC_SPINDLE	CENPF RABGAP1 LRPPRC DST ALMS1 TPX2 AKAP13 PCM1 VCL	2.18e-06	199	149	9	M5893
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TRIM2 MYCBP2 CENPF SRGAP2 RABGAP1 TRIP12 LRPPRC DST BRCA1 ANKRD17 MICAL3 GOLGA4	1.53e-05	466	149	12	M13522
Coexpression	GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN	CENPF BIRC6 DDB1 ZRANB3 LUZP1 KMT2D RNF10 TACC1	1.91e-05	199	149	8	M6264
Coexpression	GSE36009_WT_VS_NLRP10_KO_DC_UP	UACA SRGAP2 URGCP NSD3 ZBTB5 PLA2G4A ATF3 PPIP5K2	1.98e-05	200	149	8	M8775
Coexpression	TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	TRIM2 MAP2 TNC CMYA5 DST MUCL1 MICAL3 ATF3	2.45e-05	206	149	8	M14134
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	GPHN TRIM2 ANK3 DST KIAA1217 TACC1 PCCA WDR72	2.63e-05	208	149	8	M39233
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	DST AKAP13 TACC1 ATF3 KIF13A SDK1 VCL	3.07e-05	155	149	7	M39246
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	GPHN ANK2 MCC DDB1 SNX19 DCAF5 ZNF568 RANBP17 KIAA1217 TPX2 ANKRD17 ASTN2 TNFRSF19 ATF3 SDK1 PCM1 CDON	6.35e-05	1009	149	17	M157
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	CENPF SANBR RTN3 LUZP1 ALMS1 BRCA1 TPX2 GOLGA4 PCM1	8.33e-06	192	148	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP DST AKAP13 NEXN VCL	3.35e-11	184	149	11	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP KIAA1217 AKAP13 MICAL3 NEXN	4.47e-11	189	149	11	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP DST AKAP13 MICAL3 NEXN	4.73e-11	190	149	11	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	GPHN COL19A1 ANK3 CMIP IGF1R ANKRD17 AKAP13 PCCA SDK1 GOLGA4 WDR72	5.30e-11	192	149	11	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	FILIP1 COL19A1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP MICAL3 NEXN VCL	5.60e-11	193	149	11	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	FILIP1 COL19A1 ANK2 ANK3 OBSCN CMYA5 RYR2 IGF1R MLIP ASTN2 NEXN	5.92e-11	194	149	11	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	FILIP1 COL19A1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP ASTN2 MICAL3 NEXN	5.92e-11	194	149	11	c3535f7cc0076653c72db582047cff053c322397
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP DST AKAP13 MICAL3 NEXN	6.26e-11	195	149	11	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP AKAP13 MICAL3 NEXN	9.34e-10	190	149	10	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP DST AKAP13 NEXN	9.83e-10	191	149	10	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 OBSCN GRID1 PKD1L2 RYR2 ROBO1 MYO15A DNAH5 SDK1	1.25e-08	184	149	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 OBSCN GRID1 PKD1L2 RYR2 ROBO1 MYO15A DNAH5 SDK1	1.25e-08	184	149	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL19A1 OBSCN GRID1 PKD1L2 RYR2 ROBO1 MYO15A DNAH5 SDK1	1.25e-08	184	149	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP NEXN VCL	1.31e-08	185	149	9	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 IGF1R MLIP NEXN	1.51e-08	188	149	9	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP MICAL3 HADHA VCL	1.58e-08	189	149	9	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP AKAP13 MICAL3 NEXN	1.58e-08	189	149	9	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP MICAL3 NEXN	1.73e-08	191	149	9	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GPHN ANK3 CMYA5 IGF1R ASTN2 MICAL3 PCCA SDK1 WDR72	1.98e-08	194	149	9	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPD3 CENPF TNC CCNF IGSF10 TPX2 UGDH NEXN	1.39e-07	175	149	8	a154b28b0b2180652d51d4c7d804b3b81b35899e
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRID1 RYR2 IGSF10 HIVEP3 ABCA6 ASTN2 MICAL3 SDK1	1.73e-07	180	149	8	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK3 OBSCN CMYA5 RYR2 MLIP MICAL3 NEXN	1.88e-07	182	149	8	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIM2 MAP2 HIVEP3 DST MICAL3 RIMS2 DNAH5 VCL	2.51e-07	189	149	8	8c8ca3b30d9be6c854615459a7bfba82b427c8bc
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRIM2 MAP2 HIVEP3 DST MICAL3 RIMS2 DNAH5 VCL	2.51e-07	189	149	8	5d902a4660a27548764bf04c6de152b565da835c
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP AKAP13 NEXN	2.61e-07	190	149	8	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 UACA RYR2 DST ABCA6 ROBO1 NEXN SDK1	2.72e-07	191	149	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP MICAL3 NEXN	2.83e-07	192	149	8	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 UACA RYR2 DST ABCA6 ROBO1 NEXN SDK1	2.83e-07	192	149	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC RYR2 IGSF10 ABCA6 ROBO1 NEXN SDK1	2.83e-07	192	149	8	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GPHN ANK3 CMYA5 IGF1R ASTN2 PCCA GOLGA4 WDR72	2.94e-07	193	149	8	3866667dd221612589ae50f5c52f73a183a49ce6
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC RYR2 IGSF10 ABCA6 ROBO1 NEXN SDK1	3.06e-07	194	149	8	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC DST ABCA6 KIAA1217 PLA2G4A ROBO1 VCL	3.06e-07	194	149	8	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 TNC DST ABCA6 KIAA1217 PLA2G4A ROBO1 VCL	3.06e-07	194	149	8	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 ANK3 OBSCN CMYA5 RYR2 MLIP NEXN	3.18e-07	195	149	8	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	GPHN COL19A1 ANK3 HIVEP3 RANBP17 IGF1R PCCA SDK1	3.31e-07	196	149	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 UACA TNC ABCA6 KIAA1217 PLA2G4A NEXN VCL	3.31e-07	196	149	8	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	GPHN COL19A1 ANK3 RANBP17 IGF1R KIF13A PCCA SDK1	3.58e-07	198	149	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 UACA RYR2 DST ABCA6 ROBO1 NEXN SDK1	3.58e-07	198	149	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK2 MYCBP2 TNC RYR2 IGSF10 DST ABCA6 NEXN	3.72e-07	199	149	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK2 TNC IGSF10 DST ABCA6 ROBO1 NEXN SDK1	3.86e-07	200	149	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	ANK3 MAP2 MYCBP2 RTN3 COPG2 RYR2 KCNH1 RIMS2	3.86e-07	200	149	8	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYCBP2 TRIP12 BIRC6 ACIN1 AKAP13 GOLGA4 PCM1 SON	3.86e-07	200	149	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP NEXN	1.74e-06	170	149	7	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP NEXN	2.19e-06	176	149	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	ZRANB3 NBAS DST PPP1R15B IL23R PCM1 HTT	2.27e-06	177	149	7	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP NEXN	2.63e-06	181	149	7	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	UACA TNC RYR2 IGSF10 ABCA6 ROBO1 TNFRSF19	2.63e-06	181	149	7	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP NEXN	2.93e-06	184	149	7	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP NEXN	3.04e-06	185	149	7	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 TNC IGSF10 CLIP3 ASTN2 CDON	3.04e-06	185	149	7	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 TNC IGSF10 CLIP3 ASTN2 CDON	3.04e-06	185	149	7	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 MAP2 TNC IGSF10 CLIP3 ASTN2 CDON	3.04e-06	185	149	7	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	LV-03._Atrial_Cardiomyocyte\|LV / Chamber and Cluster_Paper	GOLGA8S ANK3 CMYA5 RYR2 MLIP NEXN	3.19e-06	120	149	6	3b77bd0e3630cdd45001cecf5e47660a90ebc92e
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 NSD3 TAF3 ATF3 GOLGA4 PCM1 SON	3.27e-06	187	149	7	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	UACA RYR2 DST ABCA6 ROBO1 NEXN SDK1	3.27e-06	187	149	7	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FILIP1 ANK3 UACA SANBR RYR2 LUZP1 KIF13A	3.38e-06	188	149	7	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FILIP1 ANK3 UACA SANBR RYR2 LUZP1 KIF13A	3.38e-06	188	149	7	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	MAP2 TNC RYR2 KIF13A NEXN SDK1 VCL	3.38e-06	188	149	7	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FILIP1 ANK3 UACA SANBR RYR2 LUZP1 KIF13A	3.38e-06	188	149	7	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	OBSCN CMYA5 RYR2 MLIP MICAL3 NEXN	3.51e-06	122	149	6	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FILIP1 ANK2 OBSCN CMYA5 RYR2 MLIP NEXN	3.63e-06	190	149	7	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC GRID1 RYR2 HIVEP3 ROBO1 SDK1	3.63e-06	190	149	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ANK2 UACA RYR2 DST ABCA6 ROBO1 SDK1	3.63e-06	190	149	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC RYR2 IGSF10 ABCA6 ROBO1 SDK1	3.75e-06	191	149	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNC GRID1 RYR2 IGSF10 ASTN2 TNFRSF19 SDK1	3.75e-06	191	149	7	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRIM2 HIVEP3 ASTN2 RIMS2 LNX1 DNAH5 NEXN	3.75e-06	191	149	7	9032aa974aa1b7b1095b8d1b58dcb087358a5001
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRIM2 HIVEP3 ASTN2 RIMS2 LNX1 DNAH5 NEXN	3.75e-06	191	149	7	5717809a1476c20f65bce722c5a57cff92ee0d7a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC IGSF10 ABCA6 ROBO1 NEXN SDK1	3.89e-06	192	149	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC GRID1 RYR2 IGSF10 ABCA6 SDK1	3.89e-06	192	149	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	UACA MAP2 TNC RYR2 HIVEP3 DST ROBO1	3.89e-06	192	149	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FILIP1 ANK2 MAP2 IGSF10 CLIP3 ASTN2 CDON	4.02e-06	193	149	7	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC IGSF10 ABCA6 ROBO1 ASTN2 SDK1	4.02e-06	193	149	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	ANK2 UACA WT1 RYR2 DST ABCA6 ROBO1	4.16e-06	194	149	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	UACA RYR2 DST ABCA6 ROBO1 NEXN SDK1	4.30e-06	195	149	7	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FILIP1 MYCBP2 DDB1 DST GOLGA4 PCM1 SON	4.30e-06	195	149	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	RYR2 IGSF10 DST ABCA6 ROBO1 NEXN SDK1	4.30e-06	195	149	7	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANK2 UACA RYR2 DST ABCA6 ROBO1 SDK1	4.45e-06	196	149	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK2 TNC RYR2 IGSF10 DST ABCA6 NEXN	4.60e-06	197	149	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	UACA TNC RYR2 DST ABCA6 ROBO1 SDK1	4.60e-06	197	149	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	UACA TNC RYR2 DST ABCA6 ROBO1 SDK1	4.92e-06	199	149	7	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	ANK2 ANK3 MAP2 OSTN RYR2 DST RIMS2	4.92e-06	199	149	7	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANK2 TNC IGSF10 DST ABCA6 ROBO1 NEXN	4.92e-06	199	149	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	ANK2 ANK3 MAP2 OSTN RYR2 DST RIMS2	4.92e-06	199	149	7	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK2 TNC RYR2 IGSF10 HIVEP3 ABCA6 SDK1	4.92e-06	199	149	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TRIM2 ANK3 UACA TNC IGF1R DST KIAA1217	5.08e-06	200	149	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	UACA TNC RYR2 IGSF10 DST ABCA6 NEXN	5.08e-06	200	149	7	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRIM2 ANK3 MCC RANBP17 KIAA1217 TNFRSF19 LNX1	5.08e-06	200	149	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	UACA TNC RYR2 IGSF10 DST ABCA6 NEXN	5.08e-06	200	149	7	a510deaada669e690329183e18df02870bd204b3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 UACA RYR2 DST ABCA6 ROBO1 SDK1	5.08e-06	200	149	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ANK2 MYCBP2 TNC RYR2 DST ABCA6 NEXN	5.08e-06	200	149	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UACA RYR2 DST ABCA6 ROBO1 NEXN SDK1	5.08e-06	200	149	7	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ANK2 TNC IGSF10 DST ABCA6 ROBO1 NEXN	5.08e-06	200	149	7	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	UACA TNC RYR2 IGSF10 DST ABCA6 NEXN	5.08e-06	200	149	7	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK2 ANK3 DST ABCA6 KIAA1217 ASTN2	2.19e-05	168	149	6	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNC PCDHB14 WT1 MCC ROBO1 ASTN2	2.26e-05	169	149	6	87116c33c5ca8cb1862e103e5607b1df4d264569
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ANK2 PCDHB14 DST KCNH1 ROBO1 WDR72	2.34e-05	170	149	6	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NCAPD3 CENPF CCNF TPX2 UGDH NEXN	2.50e-05	172	149	6	c06ca5d075937747952ed915c9db39a9f62072f9
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SNX19 FAM186A NFRKB C19orf44 PCM1	2.51e-05	103	149	5	1b2edf25d6b845e7c07470b2a034654d63917c01
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP2 CENPF TNC CCNF IGSF10 TPX2	2.75e-05	175	149	6	cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9
ToppCell	10x_5'_v1-Neoplastic-Stem-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAP2 CENPF TNC CCNF IGSF10 TPX2	2.75e-05	175	149	6	a8400e7e47379901dcab5f2e364c3ff17765b4b9
Computational	Neighborhood of PRKAG1	POLR2A KDM3B DDB1 LRPPRC KMT2D ZPR1 NFRKB ANKRD17 ILVBL TP53BP1	2.05e-05	224	92	10	MORF_PRKAG1
Computational	Neighborhood of EIF4E	KDM3B CCNF ZPR1 NFRKB ANKRD17 NUP93	8.47e-05	85	92	6	MORF_EIF4E
Computational	Neighborhood of CDC10	POLR2A KDM3B DDB1 LRPPRC ZPR1 TACC1 TP53BP1	2.47e-04	146	92	7	MORF_CDC10
Computational	Neighborhood of DDB1	POLR2A KDM3B DDB1 LRPPRC ZPR1 NFRKB ANKRD17 ILVBL TP53BP1	2.47e-04	246	92	9	MORF_DDB1
Computational	Neighborhood of FANCG	POLR2A KDM3B DDB1 CCNF KMT2D NFRKB ILVBL	5.57e-04	167	92	7	MORF_FANCG
Computational	Neighborhood of PHB	POLR2A DDB1 ZPR1 NFRKB ILVBL TP53BP1	6.91e-04	125	92	6	MORF_PHB
Computational	Genes upregulated in subsets of cells of a given type within various tumors	UACA DST GOLGA4 PCM1	8.57e-04	50	92	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Neighborhood of RTN1	TRIM2 ANK2 SRGAP2 CLIP3	9.94e-04	52	92	4	GNF2_RTN1
Computational	Neighborhood of USP5	POLR2A DDB1 ZPR1 ILVBL	9.94e-04	52	92	4	MORF_USP5
Drug	5114445; Up 200; 10uM; MCF7; HT_HG-U133A_EA	CLCA4 LUZP1 PRKD3 NFRKB ASTN2 AKAP13 ATF3 PCK2 ZMYM6 CDON	5.69e-07	192	149	10	901_UP
Disease	waist-hip ratio	ANK3 MYCBP2 WT1 MCC DGKQ SRGAP2 TRIP12 BIRC6 ZNF568 MEFV CMIP IGF1R MLIP UBN1 ROBO1 ASTN2 TBC1D23 HTT CDON	7.82e-06	1226	143	19	EFO_0004343
Disease	Alzheimer's disease (implicated_via_orthology)	ANK2 MAP2 NCSTN HIVEP3 IGF1R	8.52e-06	57	143	5	DOID:10652 (implicated_via_orthology)
Disease	hippocampal volume	MAP2 MYCBP2 OSTN RABGAP1 RYR2 KIAA1217 ASTN2 AKAP13 LNX1	1.54e-05	297	143	9	EFO_0005035
Disease	cortical thickness	MYCBP2 OSTN SRGAP2 RABGAP1 LUZP1 IGF1R UBN1 XPO5 TPX2 ROBO1 ASTN2 MICAL3 TACC1 KIF13A LNX1 PCCA KDM4B	2.93e-05	1113	143	17	EFO_0004840
Disease	nephroblastoma (is_implicated_in)	WT1 REST IGF1R	3.90e-05	14	143	3	DOID:2154 (is_implicated_in)
Disease	Colorectal Carcinoma	ANK2 MAP2 CD109 OBSCN MCC GRID1 ABCC6 HIVEP3 ABCA6 TPX2 ACIN1 B4GALNT2 GABRA6	3.95e-05	702	143	13	C0009402
Disease	response to anti-tuberculosis drug, drug-induced liver injury	ROBO1 ASTN2	6.97e-05	3	143	2	EFO_0004228, EFO_0007918
Disease	Osteoarthritis of hip	FILIP1 TNC ASTN2	1.20e-04	20	143	3	C0029410
Disease	cholesterol to total lipids in large HDL percentage	CMIP ZPR1 NUP93 TP53BP1	1.49e-04	55	143	4	EFO_0022234
Disease	smoking status measurement	GRID1 REST BIRC6 DCAF5 RYR2 RANBP17 LRPPRC IGF1R ALMS1 PCCA SDK1 ADAT1 PCK2 KDM4B GABRA6 WDR72	1.66e-04	1160	143	16	EFO_0006527
Disease	free cholesterol to total lipids in medium VLDL percentage	CMIP ABCA6 ZPR1 TP53BP1	1.71e-04	57	143	4	EFO_0022284
Disease	frailty measurement	ANK3 LRPPRC HTT	1.84e-04	23	143	3	EFO_0009885
Disease	triglycerides to total lipids in small LDL percentage	CMIP ABCA6 ZPR1 TP53BP1	1.96e-04	59	143	4	EFO_0022337
Disease	cholesteryl esters to total lipids in large HDL percentage	CMIP ZPR1 NUP93 TP53BP1	1.96e-04	59	143	4	EFO_0022248
Disease	pancreatic carcinoma	NCAPD3 ARRDC5 GRID1 DST MICAL3 TACC1	2.11e-04	174	143	6	EFO_0002618
Disease	Insulinogenic index measurement	MYCBP2 PPIP5K2	2.31e-04	5	143	2	EFO_0009961
Disease	Malignant neoplasm of breast	COL19A1 ANK2 CENPF CD109 OBSCN WT1 BAP1 KMT2D IGF1R BRCA1 KCNH1 PLA2G4A ROBO1 ASTN2 TP53BP1	2.35e-04	1074	143	15	C0006142
Disease	triglycerides to total lipids in IDL percentage	CMIP ABCA6 ZPR1 TP53BP1	2.52e-04	63	143	4	EFO_0022329
Disease	triglycerides to total lipids in medium VLDL percentage	CMIP ABCA6 ZPR1 TP53BP1	2.52e-04	63	143	4	EFO_0022335
Disease	cholesterol to total lipids in medium VLDL percentage	CMIP ABCA6 ZPR1 TP53BP1	2.52e-04	63	143	4	EFO_0022239
Disease	Mammary Carcinoma, Human	CENPF CD109 WT1 BAP1 KMT2D IGF1R BRCA1 KCNH1 PLA2G4A TP53BP1	2.53e-04	525	143	10	C4704874
Disease	Mammary Neoplasms, Human	CENPF CD109 WT1 BAP1 KMT2D IGF1R BRCA1 KCNH1 PLA2G4A TP53BP1	2.53e-04	525	143	10	C1257931
Disease	Mammary Neoplasms	CENPF CD109 WT1 BAP1 KMT2D IGF1R BRCA1 KCNH1 PLA2G4A TP53BP1	2.60e-04	527	143	10	C1458155
Disease	ergothioneine measurement	RIMS2 LNX1 DNAH5	2.67e-04	26	143	3	EFO_0021163
Disease	breast cancer (is_marker_for)	WT1 KDM3B KMT2D IGF1R BRCA1 KDM4B	2.94e-04	185	143	6	DOID:1612 (is_marker_for)
Disease	corpus callosum mid-anterior volume measurement	OSTN LNX1 WDR72	2.99e-04	27	143	3	EFO_0010297
Disease	Breast Carcinoma	CENPF CD109 WT1 BAP1 KMT2D IGF1R BRCA1 KCNH1 PLA2G4A TP53BP1	3.07e-04	538	143	10	C0678222
Disease	cholesterol to total lipids in very small VLDL percentage	CMIP ABCA6 ZPR1 TP53BP1	3.20e-04	67	143	4	EFO_0022245
Disease	intelligence, response to cranial radiation therapy	TRIM2 WT1 NUP93	3.34e-04	28	143	3	EFO_0004337, EFO_0010950
Disease	corpus callosum central volume measurement	TMEM190 OSTN LNX1	3.34e-04	28	143	3	EFO_0010296
Disease	triglycerides to total lipids in very small VLDL percentage	CMIP ABCA6 ZPR1 TP53BP1	3.58e-04	69	143	4	EFO_0022341
Disease	Bilateral Wilms Tumor	WT1 REST XPO5	3.71e-04	29	143	3	C2930471
Disease	cholesteryl esters to total lipids in very small VLDL percentage	CMIP ABCA6 ZPR1 TP53BP1	3.99e-04	71	143	4	EFO_0022259
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	WT1 XPO5 NUP93	4.11e-04	30	143	3	C1868672
Disease	pulse pressure measurement	ANK2 WT1 RABGAP1 SNX19 LUZP1 NSD3 PRKD3 HIVEP3 MLIP KIAA1217 AKAP13 LNX1 GOLGA4 PCM1 KDM4B VCL GABRA6	4.27e-04	1392	143	17	EFO_0005763
Disease	diastolic blood pressure, systolic blood pressure	ANK2 ANK3 SNX19 RYR2 CMIP ALMS1 LNX1 NEXN SREK1IP1 PCM1 GABRA6	4.40e-04	670	143	11	EFO_0006335, EFO_0006336
Disease	free cholesterol to total lipids in large LDL percentage	CMIP ABCA6 ZPR1 TP53BP1	4.68e-04	74	143	4	EFO_0022280
Disease	Hidradenitis Suppurativa	NCSTN MEFV	4.82e-04	7	143	2	C0162836
Disease	Pituitary stalk interruption syndrome	ROBO1 CDON	4.82e-04	7	143	2	C4053775
Disease	free cholesterol to total lipids in small VLDL percentage	CMIP ABCA6 ZPR1 TP53BP1	4.92e-04	75	143	4	EFO_0022287
Disease	cholesterol in large HDL measurement	CMIP ZPR1 NUP93 TP53BP1	6.29e-04	80	143	4	EFO_0021900
Disease	Nephroblastoma	WT1 REST XPO5	7.08e-04	36	143	3	C0027708
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	DGKQ BIRC6 CMIP ABCA6 ZPR1 NUP93 TP53BP1	7.15e-04	303	143	7	EFO_0004612, EFO_0020945
Disease	cardiac troponin T measurement	NUGGC PKD1L2 PPIP5K2 KIF13A SDK1 VCL	7.17e-04	219	143	6	EFO_0005043
Disease	hemorrhoid	BIRC6 KIAA1217 UGDH ASTN2 MYO15A	7.67e-04	147	143	5	EFO_0009552
Disease	smoking behaviour measurement	RANBP17 LRPPRC IGF1R ASTN2 SDK1 ADAT1	7.69e-04	222	143	6	EFO_0005671
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	CMIP ABCA6 ZPR1 NUP93 TP53BP1 HTT	7.69e-04	222	143	6	EFO_0008317, EFO_0020943
Disease	cortical surface area measurement	FILIP1 NCAPD3 TRIM2 ANK3 MAP2 MYCBP2 OSTN REST LUZP1 STRIP1 USP38 ROBO1 ASTN2 TACC1 LNX1 PCCA	8.39e-04	1345	143	16	EFO_0010736
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	CMIP ABCA6 ZPR1 TP53BP1 HTT	8.40e-04	150	143	5	EFO_0004611, EFO_0020947
Disease	dentate gyrus volume measurement	RABGAP1 ASTN2 LNX1	8.96e-04	39	143	3	EFO_0010083
Disease	lung cancer (is_marker_for)	TNC WT1 KDM4B	8.96e-04	39	143	3	DOID:1324 (is_marker_for)
Disease	age at menarche, spine bone mineral density	WHRN KCNH1	1.02e-03	10	143	2	EFO_0004703, EFO_0007701
Disease	myelodysplastic syndrome	GRID1 PLA2G4A	1.02e-03	10	143	2	EFO_0000198
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	ANK2 RYR2	1.02e-03	10	143	2	C1631597
Disease	alcohol consumption measurement	GRID1 REST BIRC6 RANBP17 NBAS LRPPRC MLIP ALMS1 ASTN2 MICAL3 MYO15A RIMS2 DNAH5 SDK1 HTT	1.05e-03	1242	143	15	EFO_0007878
Disease	Neurodevelopmental Disorders	ANK2 TRIP12 HIVEP3 KCNH1	1.11e-03	93	143	4	C1535926
Disease	total hip arthroplasty, osteoarthritis	FILIP1 TNC ASTN2	1.11e-03	42	143	3	EFO_0009806, MONDO_0005178
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	CMIP ABCA6 ZPR1 NUP93 TP53BP1 HTT	1.13e-03	239	143	6	EFO_0008317, EFO_0020945
Disease	free cholesterol to total lipids in very small VLDL percentage	ABCA6 ZPR1 TP53BP1	1.19e-03	43	143	3	EFO_0022290
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	ZPR1 B4GALNT2	1.25e-03	11	143	2	OBA_2045170
Disease	Familial dilated cardiomyopathy	TXNRD2 NEXN VCL	1.28e-03	44	143	3	C0340427
Disease	risk-taking behaviour	MAP2 REST BIRC6 RYR2 HIVEP3 LRPPRC IGF1R USPL1 PCCA SDK1 HTT	1.28e-03	764	143	11	EFO_0008579
Disease	Diuretic use measurement	WT1 CMIP USP38 FAM186A AKAP13	1.43e-03	169	143	5	EFO_0009928
Disease	level of C-X-C motif chemokine 2 in blood serum	NCSTN TELO2	1.49e-03	12	143	2	OBA_2041207
Disease	triacylglycerol 58:12 measurement	TRIP12 LNX1	1.49e-03	12	143	2	EFO_0010439
Disease	cognitive function measurement	POLR2A COPG2 GRID1 BIRC6 STRIP1 LRPPRC KMT2D ALMS1 KIAA1217 RNF10 MAST1 TACC1 DNAH5 SREK1IP1 SDK1 KDM4B	1.63e-03	1434	143	16	EFO_0008354
Disease	hippocampal CA1 volume	OSTN RABGAP1 ASTN2	1.64e-03	48	143	3	EFO_0009394
Disease	taurolithocholate 3-sulfate measurement	IGF1R PLA2G4A	1.76e-03	13	143	2	EFO_0021036
Disease	triglycerides to total lipids in medium LDL percentage	ABCA6 ZPR1 TP53BP1	1.85e-03	50	143	3	EFO_0022334
Disease	cholesteryl esters to total lipids in IDL percentage	CMIP ZPR1 TP53BP1	1.85e-03	50	143	3	EFO_0022247
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	CMIP ABCA6 ZPR1 NUP93 TP53BP1 HTT	1.86e-03	264	143	6	EFO_0008317, EFO_0020944
Disease	phospholipids in very small VLDL measurement	ABCA6 ZPR1 TP53BP1	1.96e-03	51	143	3	EFO_0022300
Disease	cholesterol to total lipids in small VLDL percentage	CMIP ABCA6 ZPR1	1.96e-03	51	143	3	EFO_0022242
Disease	coronary artery disease	CD109 WT1 REST IGSF10 CMIP ZPR1 KIAA1217 B4GALNT2 ASTN2 AKAP13 ATF3 LNX1 KDM4B WDR72	2.04e-03	1194	143	14	EFO_0001645
Disease	triglycerides to total lipids in very large VLDL percentage	CMIP ABCA6 ZPR1	2.19e-03	53	143	3	EFO_0022340
Disease	cholesteryl esters to total lipids in very large VLDL percentage	CMIP ABCA6 ZPR1	2.19e-03	53	143	3	EFO_0022258
Disease	atrial fibrillation	FILIP1 POLR2A SANBR IGF1R ASTN2 PCCA PCM1	2.28e-03	371	143	7	EFO_0000275
Disease	cholesterol to total lipids in very large VLDL percentage	CMIP ABCA6 ZPR1	2.31e-03	54	143	3	EFO_0022244
Disease	level of C-X-C motif chemokine 3 in blood serum	NCSTN TELO2	2.35e-03	15	143	2	OBA_2041208
Disease	triglycerides in large VLDL measurement	CMIP ZPR1 TP53BP1	2.56e-03	56	143	3	EFO_0022178
Disease	triglycerides in very large VLDL measurement	CMIP ZPR1 TP53BP1	2.56e-03	56	143	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	CMIP ZPR1 TP53BP1	2.56e-03	56	143	3	EFO_0022333
Disease	cholesteryl esters to total lipids in medium HDL percentage	CMIP ZPR1 TP53BP1	2.56e-03	56	143	3	EFO_0022251
Disease	FEV/FEC ratio	MAP2 MCC SRGAP2 REST HIVEP3 DST ASTN2 MICAL3 MYO15A KIF13A LNX1 DNAH5 NEXN CDON	2.63e-03	1228	143	14	EFO_0004713
Disease	thyroid volume	IGF1R DNAH5	2.68e-03	16	143	2	EFO_0004865
Disease	Hypertrophic Cardiomyopathy	OBSCN RYR2 VCL	2.69e-03	57	143	3	C0007194
Disease	triglycerides to total lipids in small VLDL percentage	CMIP ABCA6 ZPR1	2.83e-03	58	143	3	EFO_0022338
Disease	colorectal cancer (is_implicated_in)	MCC BRCA1 XPO5 KDM4B	2.90e-03	121	143	4	DOID:9256 (is_implicated_in)
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	CMIP ABCA6 ZPR1 TP53BP1 HTT	2.97e-03	200	143	5	EFO_0004611, EFO_0020945
Disease	multiple myeloma (is_implicated_in)	MEFV XPO5 ROBO1	2.97e-03	59	143	3	DOID:9538 (is_implicated_in)
Disease	triglycerides in VLDL measurement	CMIP ZPR1 TP53BP1	2.97e-03	59	143	3	EFO_0022326
Disease	Fetal Alcohol Syndrome	ANK3 REST	3.02e-03	17	143	2	C0015923
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DGKQ CMIP ABCA6 ZPR1 TP53BP1 HTT	3.02e-03	291	143	6	EFO_0008317, EFO_0020946
Disease	peak expiratory flow	ANK3 GRID1 IGF1R DST ASTN2 MICAL3 PCCA NEXN	3.04e-03	498	143	8	EFO_0009718
Disease	mean arterial pressure	TRIP12 PRKD3 HIVEP3 CMIP KIAA1217 ROBO1 LNX1 KDM4B	3.08e-03	499	143	8	EFO_0006340
Disease	phospholipids in small VLDL measurement	ABCA6 ZPR1 TP53BP1	3.12e-03	60	143	3	EFO_0022146
Disease	triglycerides to total lipids in large HDL percentage	CMIP ZPR1 TP53BP1	3.12e-03	60	143	3	EFO_0022330
Disease	cholesterol to total lipids in IDL percentage	CMIP ZPR1 TP53BP1	3.12e-03	60	143	3	EFO_0022233
Disease	cholesterol to total lipids in medium HDL percentage	CMIP ZPR1 TP53BP1	3.12e-03	60	143	3	EFO_0022237
Disease	free cholesterol to total lipids in medium HDL percentage	CMIP ZPR1 NUP93	3.12e-03	60	143	3	EFO_0022282

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISIVRPFSIETKDST	TACC1	146	O75410
KSGVSITIDDPVRTA	ACIN1	986	Q9UKV3
PTSASILSVAVREAE	EGFL8	191	Q99944
DRVSDTPSITAKLIS	BIRC6	3871	Q9NR09
IVSLESRSSVAKFPV	B4GALNT2	286	Q8NHY0
RTATALTTSILDEKP	ABCA6	1261	Q8N139
STRKVSSDTLETIAP	AKAP13	46	Q12802
STTVRSPLQEAESKV	ALMS1	2356	Q8TCU4
VERTSTAKPALTASA	CMIP	406	Q8IY22
RVTPKSTARSVVLEV	DGKQ	416	P52824
SSPVEKEVVEATDSR	BAP1	596	Q92560
VPSSRDTALTIAADK	ANKRD17	1316	O75179
KTVTVSTLPALRESD	ASTN2	66	O75129
ATVTRIAPGSAKVID	ADAT1	241	Q9BUB4
SPTDIKTVREVTAAL	CFAP206	146	Q8IYR0
ISSSLVSDVVRPKTQ	MLIP	166	Q5VWP3
TPATDALKNRSSVEV	NUP93	236	Q8N1F7
PEITKAFITSRLDSV	RANBP17	406	Q9H2T7
ISKRLSVVSRVPFTE	RBM45	246	Q8IUH3
TAAAIAAKIPDSIIS	GPHN	236	Q9NQX3
ELAVVPDSRSVKVSQ	GOLGA8S	81	H3BPF8
TGTLKPDDRVVVAAT	NCSTN	266	Q92542
TSVVDSEPVRFTVKV	NEXN	591	Q0ZGT2
ESGVPVLVTSESRKV	ANK2	2646	Q01484
ITKESPQDSAITRDI	RABGAP1	596	Q9Y3P9
PSAVEEREAVSKTAL	REST	976	Q13127
NAEEKAVLIASTRSP	MICAL3	636	Q7RTP6
TVASSEAKPAATIRI	NFRKB	1076	Q6P4R8
RKEVAETSAGPSVVS	ALAS1	141	P13196
REKIFTPLTVESAVD	MYO15A	1536	Q9UKN7
QVSREAVALVKPVTS	MYO15A	2631	Q9UKN7
PLVTESVKRAVVSTA	MYO15A	2751	Q9UKN7
KSVESSQSETLIVPR	GOLGA4	1696	Q13439
LISAVTTPAKAIAAV	DST	4441	Q03001
KVPIIITSASVDSAI	ARRDC5	311	A6NEK1
LPTSVRSSVEDTVKN	FSIP2	3206	Q5CZC0
SISDIPVSKIASFII	FSIP2	4886	Q5CZC0
PETRVAIKTVNEAAS	IGF1R	1026	P08069
TAESKNVPLEREATS	PCM1	1846	Q15154
DVARVESKTVIVTPS	PCK2	101	Q16822
ATTAASTTARKDIPV	MUCL1	61	Q96DR8
DITAKLDSPRVTVAQ	EEF2KMT	211	Q96G04
RASPTSDIESVERKI	DCAF5	646	Q96JK2
VSVTESGEIKSVDPR	KDM3B	231	Q7LBC6
RSPLSVVKQEASSDE	KDM4B	621	O94953
SLVKASVVTVRESPA	KCNH1	781	O95259
VPTAEEIAETLASTK	LAX1	196	Q8IWV1
ERDEEAVKTISPSTS	PRKD3	381	O94806
EITSIKINRVDPSES	LNX1	271	Q8TBB1
KDLPVTEAVFSALVT	LRPPRC	226	P42704
IVSSSEANKVLTRAP	GABRA6	381	Q16445
RSLEVTISTGEKAPA	MEFV	241	O15553
LEKVTEDTSSVLRSP	PCCA	651	P05165
AVAVERVTKSPGETS	NSFL1C	131	Q9UNZ2
DLITVVDAVTFSPKA	NBAS	1891	A2RRP1
ISSESARSKTEEAVP	LRRC66	716	Q68CR7
KVAVTTTPFENTSIR	MAST1	1046	Q9Y2H9
TPEAVTKDVSRIVSS	PKD1L2	1651	Q7Z442
IDVQSTPTVREEKSA	OSTN	41	P61366
TPTVREEKSATDLTA	OSTN	46	P61366
VSFSRPLQDVVTTEK	OBSCN	2166	Q5VST9
EERTSATLTVKALPA	OBSCN	3436	Q5VST9
QKTAASLRVTEPEVT	OBSCN	4146	Q5VST9
IASDIASDRKRSPSV	RIMS2	256	Q9UQ26
EVTISSITKRIPENA	PCDHB14	346	Q9Y5E9
SVSREKPELTASTER	BRCA1	1631	P38398
SEKVSLRISVTQPDS	CD109	571	Q6YHK3
SSSNDIPIAKIAERV	MCC	316	P23508
TSKRPEESVQETLAA	HTT	216	P42858
KADIARVPSEESTTL	IGSF10	1091	Q6WRI0
SFSKAREEEITPVVS	C17orf99	16	Q6UX52
LTPTSADKLRAAVET	ILVBL	296	A1L0T0
VDSGTILREPTTKSV	CENPF	3056	P49454
LVRTSREPGKDVTTS	CCNF	686	P41002
FLLPASTSVTVRDKT	COL19A1	16	Q14993
VKLVSSPGRSEAETV	C19orf44	331	Q9H6X5
TRAVKEEIPTDSSLI	CMYA5	1366	Q8N3K9
SKLSVEVRSLEPGST	CDON	776	Q4KMG0
ASERSVPATKIEITV	CPNE9	6	Q8IYJ1
SRAETINATVPKTII	IL23R	226	Q5VWK5
VKSISDVASPIRSFR	ANK3	1561	Q12955
TVSDRPLGVSITKAE	ATF3	66	P18847
RSKERTPVDVILASV	COPG2	856	Q9UBF2
ITVSAELPAFTKDTI	DRC7	61	Q8IY82
ETVVSRSSIIIKPSD	LUZP1	871	Q86V48
TSALPISEIAAVSKR	HADHA	476	P40939
TITPERESVVDFSKR	GRID1	521	Q9ULK0
VAKETSESTRVLESP	FAM186A	646	A6NE01
RTFTTVRTPKDIASE	CLIP3	511	Q96DZ5
LTPSSTSRIVVEKDG	SDK1	616	Q7Z5N4
TSDPEKTVERVLDIA	RYR2	3541	Q92736
SVVEGKELPTRSSSE	RYR2	4526	Q92736
ITSASVRLVSQEPKA	DDB1	471	Q16531
SEEVRDSVTKLVPLT	DNAH5	2756	Q8TE73
SAIKSSESPRDSVVR	FAM126B	391	Q8IXS8
SPISFLVVKVSATDV	PCDHB8	256	Q9UN66
VELFISTTPDSRKRT	PLA2G4A	46	P47712
FSSVVAPKVIVDTLS	OR4C6	71	Q8NH72
VLEKEVSRSPTTSSI	KIF13A	1581	Q9H1H9
SQKPITIRETTRVDA	RTN3	806	O95197
ALSTPVVEKRSASSE	GTF2E2	16	P29084
SGASAKAPVRSVVTE	TAF3	836	Q5VWG9
PTSRVITLKAEEAEE	NUGGC	226	Q68CJ6
ISAETPLKTARVEAT	TDRD6	1261	O60522
SAKPSFSISDVETIR	PLCD4	56	Q9BRC7
TVRPVNVTAEKEVST	FILIP1	1091	Q7Z7B0
EKDRTTSEAQTEVPL	ABCC6	896	O95255
SAVRKPAISLADSTD	STRIP1	201	Q5VSL9
IESTSPISRTDEIRK	KIAA1217	1646	Q5T5P2
PTATREVSVELAKVL	TELO2	546	Q9Y4R8
DLTSIVDIKTSSRPA	MYCBP2	3741	O75592
EPTSTLVRVKKSAAT	WHRN	811	Q9P202
NTSRSPKVEVSIVEV	KIF25	111	Q9UIL4
RDSKTPSESIVAISE	PPP1R15B	586	Q5SWA1
RDVIVVPFSKDTVSD	SANBR	491	Q6NSI8
PKRDIVLDVSSTSSE	SREK1IP1	36	Q8N9Q2
RAISTPEKSISDVTF	NCAPD3	1411	P42695
AKANPETLTITVTSR	CLCA4	571	Q14CN2
VAPEIKASERRTAVA	URGCP	21	Q8TCY9
VTEKSTVPVRAAESI	UGDH	126	O60701
EVVKTDSAATRIPEL	ZPR1	116	O75312
KDISVAPRTLSQDTA	USPL1	551	Q5W0Q7
VVVSAEKIDLSPESS	ZBTB5	361	O15062
TTRPLETVTFKDVAV	ZNF568	41	Q3ZCX4
TGSVPVALSKESRDV	TMEM190	141	Q8WZ59
AQKRTREATSTPEIS	RNF4	16	P78317
RSPEKISATVVEIAG	RNF10	536	Q8N5U6
VLSEKDVDPVRTTSN	POLR2A	1346	P24928
VVERSSPKSEIEVIS	SRGAP2	791	O75044
VREKVISFIENTSTP	TBC1D23	501	Q9NUY8
TRLDAPSQIEVKDVT	TNC	801	P24821
IPTTEELKAVRVSTE	RP2	201	O75695
DTTTPIKLLAVAATA	VCL	601	P18206
VDTSEIDSVKPRRSS	HIVEP3	476	Q5T1R4
KPSRKVDASLTIDTA	WDR72	781	Q3MJ13
VAPTLVRSASETSEK	WT1	306	P19544
VTFETVEESKAPRTR	XPO5	581	Q9HAV4
KPEVTDVSRNTVTLS	ROBO1	566	Q9Y6N7
LRVPETVSAATQTIK	TP53BP1	1161	Q12888
VSAIVDTLKTAFPRS	SNX19	681	Q92543
ASKAAVLTETPRTSD	USP38	566	Q8NB14
VLTETPRTSDGEKTL	USP38	571	Q8NB14
IRTRSESEKSTEVVP	NSD3	581	Q9BZ95
SVSADAEVARRKSVP	MAP2	821	P11137
AEVARRKSVPSETVV	MAP2	826	P11137
RKSVPSETVVEDSRT	MAP2	831	P11137
SLSKDVSRLETVFVP	UACA	791	Q9BZF9
KTAVTELPSARTDTT	ZMYM6	611	O95789
LRDSTSVPVTAEAKL	ZNF416	6	Q9BWM5
VKIASTASSPRDTAL	TNFRSF19	156	Q9NS68
PDTQKILVDSREATS	TXNRD2	336	Q9NNW7
IRNPASSVEAVSKEL	UBN1	666	Q9NPG3
DVPRKTAEISSTALR	PPIP5K2	1156	O43314
VIRSADVSPTTEGVK	TRIM2	421	Q9C040
ELRVSPFETVISVKA	ZFAND4	41	Q86XD8
LTIVRKTFESTENPD	TRIP12	1936	Q14669
VAKVLEPSETLVVSS	SON	296	P18583
VVSSDPTKTAARDII	ZRANB3	551	Q5FWF4
SSLEVEAAISRKTPA	TPX2	101	Q9ULW0
IETLVVADIDSSPSK	KMT2D	1336	O14686